Industries > Pharma > Anti-obesity Drugs Market Report 2021-2031
Anti-obesity Drugs Market Report 2021-2031
Forecasts by Mechanism of Action (Incretin Mimetics/GLP-1 Agonists, Lipase Inhibitors, SNDRI's, Serotonin Receptor Agonists, Sympathomimetic-GABA Receptor Agonists, Sympathomimetics, Others), by Type (Prescription Drugs, OTC Drugs), by Duration (Short-Term, Long-Term), by Distribution Channel (Hospitals, Retail, Online) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Recovery Scenarios
Investment in Research, and Innovation is very Modest, Given the Magnitude of the Obesity Problem and its Economic Consequences
Investment in research, innovation, and experimentation is very modest, given the magnitude of the obesity problem and its economic consequences. The United Kingdom, for example, spends less than $1 billion a year on preventive efforts including weight-loss programmes and public health campaigns. To put it in context, it only accounts for approximately 1% of the societal cost of obesity in the UK. More money is needed, particularly to better understand the efficacy of intervention techniques when used as part of a larger programme. However, society should be willing to try out different treatments. Impact data from high-quality, randomised control studies is difficult to come by in many intervention areas. Rather of waiting for such evidence, relevant sections of society should be rational & take action where the risks of intervention are minimal.
Obesity is Being Driven by Social Shifts and a Global Dietary Revolution
The escalating pandemic reflects the significant changes in society and community behaviour patterns over the last several decades. While genes have a role in defining a person’s vulnerability to weight gain, calorie intake and physical exercise influence energy balance. As a result, the obesity pandemic is being driven by social shifts and a global dietary revolution. Economic development, industrialization, urbanisation, and food market globalisation are just a few of the factors believed to be driving the pandemic.
Meals rich in complex carbohydrates give way to more diverse diets with a greater percentage of lipids, saturated fats, and sweets as wages increase and people become more urban. Simultaneously, significant changes toward less physically demanding employment have been seen across the globe. Increased use of automated transportation, technology in the house, and more passive leisure activities are all signs of a shift away from physical exercise.
Which Factors are Driving the Global Anti-Obesity Drugs Market?
• Rising Obesity Awareness to Fuel Market Growth
• Growing Healthcare Expenditure Anticipated to Drive Market Growth
What are the Market Opportunities for Global Anti-Obesity Drugs Market?
• Growing Obesity Consciousness Among Public to Offer Lucrative Growth Opportunities
• COVID-19 Pandemic Anticipated to Boost Market Growth
• Emerging Economies to Offer Lucrative Growth Prospects
Discover how to stay ahead
Our 500+ page report provides 600+ tables and charts/graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Anti-Obesity Drugs Market. See how to exploit the opportunities.
Forecasts to 2031 and other analyses reveal the commercial prospects
• In addition to revenue forecasting to 2031, our new study provides you with recent results, growth rates, and market shares.
• You find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints, and challenges), PEST Analysis, Porter’s Five Forces, SWOT Analysis, product profiles and commercial developments.
Discover sales predictions for the world market and sub-markets
Mechanism of Action
• Incretin Mimetics/GLP-1 Agonists
• Lipase Inhibitors
• SNDRI’s
• Serotonin Receptor Agonists
• Sympathomimetic-GABA Receptor Agonists
• Sympathomimetics
• Others
Type
• Prescription Drugs
• OTC Drugs
Duration
• Short-Term Anti-Obesity Drugs
• Long-Term Anti-Obesity Drugs
Distribution Channel
• Hospitals
• Retail
• Online
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 18 leading national markets:
By Region
• North America
• U.S.
• Canada
• Europe
• Germany
• France
• UK
• Italy
• Spain
• Russia
• Rest of Europe
• Asia Pacific
• China
• Japan
• India
• Australia
• South Korea
• South-East Asia
• Rest of Asia Pacific
• Latin America
• Brazil
• Mexico
• Rest of Latin America
• Middle East & Africa
• GCC
• South Africa
• Rest of Middle East & Africa
Need industry data? Please contact us today.
Leading companies and the potential for market growth
Overall world revenue for anti-obesity drugs market will surpass US$xx million in 2021, our work calculates. We predict strong revenue growth through to 2031. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How the Anti-Obesity Drugs Market report helps you
In summary, our 500+ page report provides you with the following knowledge:
• Revenue forecasts to 2031 for Anti-Obesity Drugs Market, with forecasts for mechanism of action, type, duration and distribution channel, each forecasted at a global and regional level– discover the industry’s prospects, finding the most lucrative places for investments and revenues
• Revenue forecasts to 2031 for 5 regional and 18 key national markets– See forecasts for the Anti-Obesity Drugs market in North America, Europe, Asia Pacific, and Rest of the World. Also forecasted is the market in the US, Canada, Brazil, Mexico, Germany, France, UK, Italy, Spain, Russia, China, India, Japan, Australia, South Korea, South-East Asia among other prominent economies.
• Prospects for established firms and those seeking to enter the market– including company profiles for 17 of the companies involved in the Anti-Obesity Drugs Market. Some of the company’s profiled in this report include Bristol-Myers Squibb, Carmot Therapeutics, CohBar, Currax Pharmaceuticals LLC, Eisai Co. Ltd, ERX Pharmaceuticals, Gelesis, GlaxoSmithKline PLC, Hanmi Pharmaceutical, Co., Ltd., Merck & Co. Inc., Novo Nordisk A/S, Pfizer Inc., Rhythm Pharmaceuticals, Scohia Pharma, Inc., Saniona, Vivus Inc. and YSOPIA Bioscience among other prominent players.
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.
Information found nowhere else
With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Anti-Obesity Drugs Market and leading companies. You will find data, trends, and predictions.
To access the data contained in this document please email contactus@visiongain.com
Buy our report today Anti-obesity Drugs Market Report 2021-2031: Forecasts by Mechanism of Action (Incretin Mimetics/GLP-1 Agonists, Lipase Inhibitors, SNDRI’s, Serotonin Receptor Agonists, Sympathomimetic-GABA Receptor Agonists, Sympathomimetics, Others), by Type (Prescription Drugs, OTC Drugs), by Duration (Short-Term, Long-Term), by Distribution Channel (Hospitals, Retail, Online) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Recovery Scenarios. Avoid missing out by staying informed – order our report now.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
1. Report Overview
1.1 Introduction to Anti-Obesity Drugs Market
1.2 Anti-Obesity Drugs Market Definition
1.3 Why You Should Read This Report
1.4 What This Report Delivers
1.5 Key Questions Answered By This Analytical Report Include:
1.6 Who is This Report For?
1.7 Methodology
1.7.1 COVID-19 Impact: Recovery Scenarios
1.7.2 Market Evaluation & Forecasting Methodology
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain
2 Executive Summary
3 Market Dynamics
3.1 Drivers
3.1.1 Rising Obesity Awareness to Fuel Market Growth
3.1.2 Growing Healthcare Expenditure Anticipated to Drive Market Growth
3.2 Restraints
3.2.1 Lack of Understanding
3.2.2 Lack of Insurance to Restrain Market Growth
3.2.3 Clinical Trial Enrolment Challenging Market Growth
3.3 Opportunities
3.3.1 Growing Obesity Consciousness Among Public to Offer Lucrative Growth Opportunities
3.3.2 COVID-19 Pandemic Anticipated to Boost Market Growth
3.3.3 Emerging Economies to Offer Lucrative Growth Prospects
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weaknesses
3.4.3 Opportunities
3.4.4 Threats
3.5 Porter’s Five Forces Analysis
3.5.1 Buyer Power
3.5.2 Supplier Power
3.5.3 Competitive Rivalry
3.5.4 Threat of Substitute
3.5.5 Threat of New Entrants
3.6 PEST Analysis
3.6.1 Political Factors Impacting Anti-Obesity Drugs Market
3.6.2 Economic Factors Impacting Anti-Obesity Drugs Market
3.6.3 Social Factors Impacting Anti-Obesity Drugs Market
3.6.4 Technological Factors Impacting Anti-Obesity Drugs Market
4 Anti-Obesity Drugs Market by Mechanism of Action
4.1 Incretin Mimetics/GLP-1 Agonists Segment Market Forecast, 2021-2031
4.1.1 Incretin Mimetics/GLP-1 Agonists Market Overview
4.1.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
4.2 Lipase Inhibitors Segment Market Forecast, 2021-2031
4.2.1 Lipase Inhibitors Market Overview
4.2.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
4.3 SNDRI’s Segment Market Forecast, 2021-2031
4.3.1 SNDRI’s Market Overview
4.3.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
4.4 Serotonin Receptor Agonists Segment Market Forecast, 2021-2031
4.4.1 Serotonin Market Overview
4.4.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
4.5 Sympathomimetic-GABA Receptor Agonists Segment Market Forecast, 2021-2031
4.5.1 Sympathomimetic-GABA Receptor Agonists Market Revenue, 2021-2031
4.5.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
4.6 Sympathomimetics Segment Market Forecast, 2021-2031
4.6.1 Sympathomimetic Market Overview
4.6.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
4.7 Others Segment Market Forecast, 2021-2031
4.7.1 COVID-19 Impact Recovery Scenarios (V, U, W, L)
5 Anti-Obesity Drugs Market by Type
5.1 Prescription Drugs Segment Market Forecast, 2021-2031
5.1.1 Prescription Drugs Market Overview
5.1.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
5.2 OTC Drugs Segment Market Forecast, 2021-2031
5.2.1 OTC Drugs Market Overview
5.2.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
6 Anti-Obesity Drugs Market by Duration
6.1 Short-Term Anti-Obesity Drugs Segment Market Forecast, 2021-2031
6.1.1 Short-Term Anti-Obesity Drugs Market Overview
6.1.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
6.2 Long-Term Anti-Obesity Drugs Segment Market Forecast, 2021-2031
6.2.1 Long-Term Anti-Obesity Drugs Market Overview
6.2.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
7 Anti-Obesity Drugs Market by Distribution Channel
7.1 Hospitals Segment Market Forecast, 2021-2031
7.1.1 Hospitals Segment Market Overview
7.1.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
7.2 Retail Segment Market Forecast, 2021-2031
7.2.1 Retail Segment Market Overview
7.2.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
7.3 Online Segment Market Forecast, 2021-2031
7.3.1 Online Segment Market Overview
7.3.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
8 Regional and Leading National Anti-Obesity Drugs Market Forecasts 2021-2031
8.1 Global Anti-Obesity Drugs Market by Region Forecast 2021-2031
8.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
9 North America Anti-Obesity Drugs Market
9.1 North America Anti-Obesity Drugs Market by Country, Forecast 2021-2031
9.2 North America Anti-Obesity Drugs Market Forecast by Mechanism of Action
9.3 North America Anti-Obesity Drugs Market Forecast by Type
9.4 North America Anti-Obesity Drugs Market Forecast by Duration
9.5 North America Anti-Obesity Drugs Market Forecast by Distribution Channel
9.6 U.S. Anti-Obesity Drugs Market Forecast, 2021-2031
9.6.1 U.S. Anti-Obesity Drugs Market Overview
9.6.2 U.S. Anti-Obesity Drugs Market Forecast to 2031
9.6.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): U.S. Anti-Obesity Drugs Market Forecast, 2021-2031
9.7 Canada Anti-Obesity Drugs Market Forecast, 2021-2031
9.7.1 Canada Anti-Obesity Drugs Market Overview
9.7.2 Canada Anti-Obesity Drugs Market Forecast to 2031
9.7.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): Canada Anti-Obesity Drugs Market Forecast, 2021-2031
10 Europe Anti-Obesity Drugs Market
10.1 Europe Anti-Obesity Drugs Market by Country, Forecast 2021-2031
10.2 Europe Anti-Obesity Drugs Market Forecast by Mechanism of Action
10.3 Europe Anti-Obesity Drugs Market Forecast by Type
10.4 Europe Anti-Obesity Drugs Market Forecast by Duration
10.5 Europe Anti-Obesity Drugs Market Forecast by Distribution Channel
10.6 Germany Anti-Obesity Drugs Market Forecast, 2021-2031
10.6.1 Germany Anti-Obesity Drugs Market Overview
10.6.2 Germany Anti-Obesity Drugs Market Forecast to 2031
10.6.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): Germany Anti-Obesity Drugs Market Forecast, 2021-2031
10.7 UK Anti-Obesity Drugs Market Forecast, 2021-2031
10.7.1 UK Anti-Obesity Drugs Market Overview
10.7.2 UK Anti-Obesity Drugs Market Forecast to 2031
10.7.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): UK Anti-Obesity Drugs Market Forecast, 2021-2031
10.8 France Anti-Obesity Drugs Market Forecast, 2021-2031
10.8.1 France Anti-Obesity Drugs Market Overview
10.8.2 France Anti-Obesity Drugs Market Forecast to 2031
10.8.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): France Anti-Obesity Drugs Market Forecast, 2021-2031
10.9 Italy Anti-Obesity Drugs Market Forecast, 2021-2031
10.9.1 Italy Anti-Obesity Drugs Market Overview
10.9.2 Italy Anti-Obesity Drugs Market Forecast to 2031
10.9.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): Italy Anti-Obesity Drugs Market Forecast, 2021-2031
10.10 Spain Anti-Obesity Drugs Market Forecast, 2021-2031
10.10.1 Spain Anti-Obesity Drugs Market Overview
10.10.2 Spain Anti-Obesity Drugs Market Forecast to 2031
10.10.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): Spain Anti-Obesity Drugs Market Forecast, 2021-2031
10.11 Russia Anti-Obesity Drugs Market Forecast, 2021-2031
10.11.1 Russia Anti-Obesity Drugs Market Overview
10.11.2 Russia Anti-Obesity Drugs Market Forecast to 2031
10.11.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): Russia Anti-Obesity Drugs Market Forecast, 2021-2031
10.12 Rest of Europe Anti-Obesity Drugs Market Forecast, 2021-2031
10.12.1 Rest of Europe Anti-Obesity Drugs Market Overview
10.12.2 Rest of Europe Anti-Obesity Drugs Market Forecast to 2031
10.12.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): Rest of Europe Anti-Obesity Drugs Market Forecast, 2021-2031
11 Asia Pacific Anti-Obesity Drugs Market
11.1 Asia Pacific Anti-Obesity Drugs Market by Country, Forecast 2021-2031
11.2 Asia Pacific Anti-Obesity Drugs Market Forecast by Mechanism of Action
11.3 Asia Pacific Anti-Obesity Drugs Market Forecast by Type
11.4 Asia Pacific Anti-Obesity Drugs Market Forecast by Duration
11.5 Asia Pacific Anti-Obesity Drugs Market Forecast by Distribution Channel
11.6 Japan Anti-Obesity Drugs Market Forecast, 2021-2031
11.6.1 Japan Anti-Obesity Drugs Market Overview
11.6.2 Japan Anti-Obesity Drugs Market Forecast to 2031
11.6.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): Japan Anti-Obesity Drugs Market Forecast, 2021-2031
11.7 China Anti-Obesity Drugs Market Forecast, 2021-2031
11.7.1 China Anti-Obesity Drugs Market Overview
11.7.2 China Anti-Obesity Drugs Market Forecast to 2031
11.7.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): China Anti-Obesity Drugs Market Forecast, 2021-2031
11.8 India Anti-Obesity Drugs Market Forecast, 2021-2031
11.8.1 India Anti-Obesity Drugs Market Overview
11.8.2 India Anti-Obesity Drugs Market Forecast to 2031
11.8.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): India Anti-Obesity Drugs Market Forecast, 2021-2031
11.9 Australia Anti-Obesity Drugs Market Forecast, 2021-2031
11.9.1 Australia Anti-Obesity Drugs Market Overview
11.9.2 Australia Anti-Obesity Drugs Market Forecast to 2031
11.9.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): Australia Anti-Obesity Drugs Market Forecast, 2021-2031
11.10 South Korea Anti-Obesity Drugs Market Forecast, 2021-2031
11.10.1 South Korea Anti-Obesity Drugs Market Overview
11.10.2 South Korea Anti-Obesity Drugs Market Forecast to 2031
11.10.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): South Korea Anti-Obesity Drugs Market Forecast, 2021-2031
11.11 South-East Asia Anti-Obesity Drugs Market Forecast, 2021-2031
11.11.1 South-East Asia Anti-Obesity Drugs Market Forecast to 2031
11.11.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): South-East Asia Anti-Obesity Drugs Market Forecast, 2021-2031
11.12 Rest of Asia Pacific Anti-Obesity Drugs Market Forecast, 2021-2031
11.12.1 Rest of Asia Pacific Anti-Obesity Drugs Market Forecast to 2031
11.12.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): Rest of Asia Pacific Anti-Obesity Drugs Market Forecast, 2021-2031
12 Latin America Anti-Obesity Drugs Market
12.1 Latin America Anti-Obesity Drugs Market by Country, Forecast 2021-2031
12.2 Latin America Anti-Obesity Drugs Market Forecast by Mechanism of Action
12.3 Latin America Anti-Obesity Drugs Market Forecast by Type
12.4 Latin America Anti-Obesity Drugs Market Forecast by Duration
12.5 Latin America Anti-Obesity Drugs Market Forecast by Distribution Channel
12.6 Brazil Anti-Obesity Drugs Market Forecast, 2021-2031
12.6.1 Brazil Anti-Obesity Drugs Market Overview
12.6.2 Brazil Anti-Obesity Drugs Market Forecast to 2031
12.6.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): Brazil Anti-Obesity Drugs Market Forecast, 2021-2031
12.7 Mexico Anti-Obesity Drugs Market Forecast, 2021-2031
12.7.1 Mexico Anti-Obesity Drugs Market Overview
12.7.2 Mexico Anti-Obesity Drugs Market Forecast to 2031
12.7.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): Mexico Anti-Obesity Drugs Market Forecast, 2021-2031
12.8 Rest of Latin America Anti-Obesity Drugs Market Forecast, 2021-2031
12.8.1 Rest of Latin America Anti-Obesity Drugs Market Forecast to 2031
12.8.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): Rest of Latin America Anti-Obesity Drugs Market Forecast, 2021-2031
13 Middle East and Africa Anti-Obesity Drugs Market
13.1 Middle East and Africa Anti-Obesity Drugs Market by Country, Forecast 2021-2031
13.2 MEA Anti-Obesity Drugs Market Forecast by Mechanism of Action
13.3 MEA Anti-Obesity Drugs Market Forecast by Type
13.4 MEA Anti-Obesity Drugs Market Forecast by Duration
13.5 MEA Anti-Obesity Drugs Market Forecast by Distribution Channel
13.6 GCC Anti-Obesity Drugs Market Forecast, 2021-2031
13.6.1 GCC Anti-Obesity Drugs Market Overview
13.6.2 GCC Anti-Obesity Drugs Market Forecast to 2031
13.6.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): GCC Anti-Obesity Drugs Market Forecast, 2021-2031
13.7 South Africa Anti-Obesity Drugs Market Forecast, 2021-2031
13.7.1 South Africa Anti-Obesity Drugs Market Overview
13.7.2 South Africa Anti-Obesity Drugs Market Forecast to 2031
13.7.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): South Africa Anti-Obesity Drugs Market Forecast, 2021-2031
13.8 Rest of Middle East and Africa Anti-Obesity Drugs Market Forecast, 2021-2031
13.8.1 Rest of MEA Anti-Obesity Drugs Market Overview
13.8.2 Rest of MEA Anti-Obesity Drugs Market Forecast to 2031
13.8.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): Rest of Middle East and Africa Anti-Obesity Drugs Market Forecast, 2021-2031
14 Company Profiles
14.1 Bristol-Myers Squibb
14.1.1 Company Snapshot
14.1.2 Company Overview
14.1.3 Financial Analysis
14.1.4 Product Benchmarking
14.1.5 Recent Developments
14.2 Currax Pharmaceuticals LLC
14.2.1 Company Snapshot
14.2.2 Company Overview
14.2.3 Product Benchmarking
14.2.4 Recent Developments
14.3 Eisai Co. Ltd
14.3.1 Company Snapshot
14.3.2 Company Overview
14.3.3 Financial Analysis
14.3.4 Product Benchmarking
14.3.5 Recent Developments
14.4 GlaxoSmithKline PLC
14.4.1 Company Snapshot
14.4.2 Company Overview
14.4.3 Financial Analysis
14.4.4 Product Benchmarking
14.4.5 Recent Developments
14.5 Merck & Co. Inc.
14.5.1 Company Snapshot
14.5.2 Company Overview
14.5.3 Financial Analysis
14.5.4 Product Benchmarking
14.5.5 Recent Developments
14.6 Novo Nordisk A/S
14.6.1 Company Snapshot
14.6.2 Company Overview
14.6.3 Financial Analysis
14.6.4 Product Benchmarking
14.6.5 Recent Developments
14.7 Pfizer Inc.
14.7.1 Company Snapshot
14.7.2 Company Overview
14.7.3 Financial Analysis
14.7.4 Product Benchmarking
14.7.5 Recent Developments
14.8 Rhythm Pharmaceuticals
14.8.1 Company Snapshot
14.8.2 Company Overview
14.8.3 Financial Analysis
14.8.4 Product Benchmarking
14.8.5 Recent Developments
14.9 Vivus Inc.
14.9.1 Company Snapshot
14.9.2 Company Overview
14.9.3 Financial Analysis
14.9.4 Product Benchmarking
14.9.5 Recent Developments
14.10 ERX Pharmaceuticals
14.10.1 Company Snapshot
14.10.2 Company Overview
14.10.3 Product Benchmarking
14.11 CohBar
14.11.1 Company Snapshot
14.11.2 Company Overview
14.11.3 Financial Analysis
14.11.4 Product Benchmarking
Recent Developments
14.12 Carmot Therapeutics
14.12.1 Company Snapshot
14.12.2 Company Overview
14.12.3 Product Benchmarking
14.13 YSOPIA Bioscience
14.13.1 Company Snapshot
14.13.2 Company Overview
14.13.3 Product Benchmarking
14.14 Gelesis
14.14.1 Company Snapshot
14.14.2 Company Overview
14.14.3 Product Benchmarking
14.15 Scohia Pharma, Inc.
14.15.1 Company Snapshot
14.15.2 Company Overview
14.15.3 Product Benchmarking
14.16 Hanmi Pharmaceutical, Co., Ltd.
14.16.1 Company Snapshot
14.16.2 Company Overview
14.16.3 Financial Analysis
14.16.4 Product Benchmarking
14.17 Saniona
14.17.1 Company Snapshot
14.17.2 Company Overview
14.17.3 Product Benchmarking
15 Conclusion and Recommendations
15.1 Concluding Remarks
15.2 Recommendations for Market Players
List of Tables
Table 1 Global Anti-Obesity Drugs Market Snapshot, 2021 & 2031 (US$ million, CAGR %)
Table 2 Global Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 3 Global Anti-Obesity Drugs Market Forecast for Incretin Mimetics/GLP-1 Agonists Segment, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 4 Global Anti-Obesity Drugs Market Forecast for Incretin Mimetics/GLP-1 Agonists Segment, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 5 Global Anti-Obesity Drugs Market Forecast for Incretin Mimetics/GLP-1 Agonists Segment, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 6 Global Anti-Obesity Drugs Market Forecast for Incretin Mimetics/GLP-1 Agonists Segment, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 7 Global Anti-Obesity Drugs Market Forecast for Incretin Mimetics/GLP-1 Agonists Segment, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 8 Global Anti-Obesity Drugs Market Forecast for Lipase Inhibitors Segment, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 9 Global Anti-Obesity Drugs Market Forecast for Lipase Inhibitors Segment, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 10 Global Anti-Obesity Drugs Market Forecast for Lipase Inhibitors Segment, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 11 Global Anti-Obesity Drugs Market Forecast for Lipase Inhibitors Segment, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 12 Global Anti-Obesity Drugs Market Forecast for Lipase Inhibitors Segment, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 13 Global Anti-Obesity Drugs Market Forecast for SNDRI's Segment, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 14 Global Anti-Obesity Drugs Market Forecast for SNDRI's Segment, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 15 Global Anti-Obesity Drugs Market Forecast for SNDRI's Segment, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 16 Global Anti-Obesity Drugs Market Forecast for SNDRI's Segment, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 17 Global Anti-Obesity Drugs Market Forecast for SNDRI's Segment, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 18 Global Anti-Obesity Drugs Market Forecast for Serotonin Receptor Agonists Segment, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 19 Global Anti-Obesity Drugs Market Forecast for Serotonin Receptor Agonists Segment, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 20 Global Anti-Obesity Drugs Market Forecast for Serotonin Receptor Agonists Segment, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 21 Global Anti-Obesity Drugs Market Forecast for Serotonin Receptor Agonists Segment, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 22 Global Anti-Obesity Drugs Market Forecast for Serotonin Receptor Agonists Segment, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 23 Global Anti-Obesity Drugs Market Forecast for Sympathomimetic-GABA Receptor Agonists Segment, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 24 Global Anti-Obesity Drugs Market Forecast for Sympathomimetic-GABA Receptor Agonists Segment, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 25 Global Anti-Obesity Drugs Market Forecast for Sympathomimetic-GABA Receptor Agonists Segment, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 26 Global Anti-Obesity Drugs Market Forecast for Sympathomimetic-GABA Receptor Agonists Segment, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 27 Global Anti-Obesity Drugs Market Forecast for Sympathomimetic-GABA Receptor Agonists Segment, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 28 Global Anti-Obesity Drugs Market Forecast for Sympathomimetics Segment, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 29 Global Anti-Obesity Drugs Market Forecast for Sympathomimetics Segment, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 30 Global Anti-Obesity Drugs Market Forecast for Sympathomimetics Segment, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 31 Global Anti-Obesity Drugs Market Forecast for Sympathomimetics Segment, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 32 Global Anti-Obesity Drugs Market Forecast for Sympathomimetics Segment, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 33 Global Anti-Obesity Drugs Market Forecast for Others Segment, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 34 Global Anti-Obesity Drugs Market Forecast for Others Segment, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 35 Global Anti-Obesity Drugs Market Forecast for Others Segment, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 36 Global Anti-Obesity Drugs Market Forecast for Others Segment, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 37 Global Anti-Obesity Drugs Market Forecast for Others Segment, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 38 Global Anti-Obesity Drugs Market Forecast by Prescription, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 39 Global Anti-Obesity Drugs Market Forecast for Prescription Drugs Segment, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 40 Global Anti-Obesity Drugs Market Forecast for Prescription Drugs Segment, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 41 Global Anti-Obesity Drugs Market Forecast for Prescription Drugs Segment, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 42 Global Anti-Obesity Drugs Market Forecast for Prescription Drugs Segment, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 43 Global Anti-Obesity Drugs Market Forecast for Prescription Drugs Segment, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 44 Global Anti-Obesity Drugs Market Forecast for OTC Drugs Segment, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 45 Global Anti-Obesity Drugs Market Forecast for OTC Drugs Segment, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 46 Global Anti-Obesity Drugs Market Forecast for OTC Drugs Segment, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 47 Global Anti-Obesity Drugs Market Forecast for OTC Drugs Segment, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 48 Global Anti-Obesity Drugs Market Forecast for OTC Drugs Segment, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 49 Global Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 50 Global Anti-Obesity Drugs Market Forecast for Short-Term Anti-Obesity Drugs Segment, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 51 Global Anti-Obesity Drugs Market Forecast for Short-Term Anti-Obesity Drugs Segment, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 52 Global Anti-Obesity Drugs Market Forecast for Short-Term Anti-Obesity Drugs Segment, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 53 Global Anti-Obesity Drugs Market Forecast for Short-Term Anti-Obesity Drugs Segment, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 54 Global Anti-Obesity Drugs Market Forecast for Short-Term Anti-Obesity Drugs Segment, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 55 Global Anti-Obesity Drugs Market Forecast for Long-Term Anti-Obesity Drugs Segment, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 56 Global Anti-Obesity Drugs Market Forecast for Long-Term Anti-Obesity Drugs Segment, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 57 Global Anti-Obesity Drugs Market Forecast for Long-Term Anti-Obesity Drugs Segment, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 58 Global Anti-Obesity Drugs Market Forecast for Long-Term Anti-Obesity Drugs Segment, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 59 Global Anti-Obesity Drugs Market Forecast for Long-Term Anti-Obesity Drugs Segment, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 60 Global Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 61 Global Anti-Obesity Drugs Market Forecast for Hospitals Segment, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 62 Global Anti-Obesity Drugs Market Forecast for Hospitals Segment, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 63 Global Anti-Obesity Drugs Market Forecast for Hospitals Segment, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 64 Global Anti-Obesity Drugs Market Forecast for Hospitals Segment, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 65 Global Anti-Obesity Drugs Market Forecast for Hospitals Segment, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 66 Global Anti-Obesity Drugs Market Forecast for Retail Segment, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 67 Global Anti-Obesity Drugs Market Forecast for Retail Segment, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 68 Global Anti-Obesity Drugs Market Forecast for Retail Segment, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 69 Global Anti-Obesity Drugs Market Forecast for Retail Segment, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 70 Global Anti-Obesity Drugs Market Forecast for Retail Segment, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 71 Global Anti-Obesity Drugs Market Forecast for Online Segment, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 72 Global Anti-Obesity Drugs Market Forecast for Online Segment, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 73 Global Anti-Obesity Drugs Market Forecast for Online Segment, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 74 Global Anti-Obesity Drugs Market Forecast for Online Segment, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 75 Global Anti-Obesity Drugs Market Forecast for Online Segment, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 76 Global Anti-Obesity Drugs Market Forecast by Region 2021-2031 (US$ mn, AGR%, CAGR%)
Table 77 Global Anti-Obesity Drugs Market Forecast by Region 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 78 Global Anti-Obesity Drugs Market Forecast by Region 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 79 Global Anti-Obesity Drugs Market Forecast by Region 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 80 Global Anti-Obesity Drugs Market Forecast by Region 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 81 North America Anti-Obesity Drugs Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 82 North America Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 83 North America Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 84 North America Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 85 North America Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 86 North America Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 87 North America Anti-Obesity Drugs Market Forecast by Prescription, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 88 North America Anti-Obesity Drugs Market Forecast by Prescription, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 89 North America Anti-Obesity Drugs Market Forecast by Prescription, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 90 North America Anti-Obesity Drugs Market Forecast by Prescription, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 91 North America Anti-Obesity Drugs Market Forecast by Prescription, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 92 North America Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 93 North America Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 94 North America Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 95 North America Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 96 North America Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 97 North America Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 98 North America Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 99 North America Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 100 North America Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 101 North America Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 102 U.S. Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 103 U.S. Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 104 U.S. Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 105 U.S. Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 106 U.S. Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 107 Canada Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 108 Canada Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 109 Canada Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 110 Canada Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 111 Canada Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 112 Europe Anti-Obesity Drugs Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 113 Europe Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 114 Europe Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 115 Europe Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 116 Europe Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 117 Europe Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 118 Europe Anti-Obesity Drugs Market Forecast by Prescription, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 119 Europe Anti-Obesity Drugs Market Forecast by Prescription, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 120 Europe Anti-Obesity Drugs Market Forecast by Prescription, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 121 Europe Anti-Obesity Drugs Market Forecast by Prescription, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 122 Europe Anti-Obesity Drugs Market Forecast by Prescription, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 123 Europe Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 124 Europe Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 125 Europe Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 126 Europe Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 127 Europe Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 128 Europe Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 129 Europe Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 130 Europe Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 131 Europe Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 132 Europe Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 133 Germany Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 134 Germany Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 135 Germany Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 136 Germany Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 137 Germany Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 138 UK Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 139 UK Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 140 UK Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 141 UK Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 142 UK Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 143 France Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 144 France Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 145 France Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 146 France Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 147 France Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 148 Italy Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 149 Italy Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 150 Italy Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 151 Italy Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 152 Italy Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 153 Spain Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 154 Spain Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 155 Spain Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 156 Spain Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 157 Spain Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 158 Russia Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 159 Russia Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 160 Russia Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 161 Russia Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 162 Russia Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 163 Rest of Europe Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 164 Rest of Europe Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 165 Rest of Europe Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 166 Rest of Europe Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 167 Rest of Europe Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 168 Asia Pacific Anti-Obesity Drugs Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 169 Asia Pacific Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 170 Asia Pacific Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 171 Asia Pacific Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 172 Asia Pacific Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 173 Asia Pacific Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 174 Asia Pacific Anti-Obesity Drugs Market Forecast by Prescription, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 175 Asia Pacific Anti-Obesity Drugs Market Forecast by Prescription, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 176 Asia Pacific Anti-Obesity Drugs Market Forecast by Prescription, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 177 Asia Pacific Anti-Obesity Drugs Market Forecast by Prescription, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 178 Asia Pacific Anti-Obesity Drugs Market Forecast by Prescription, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 179 Asia Pacific Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 180 Asia Pacific Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 181 Asia Pacific Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 182 Asia Pacific Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 183 Asia Pacific Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 184 Asia Pacific Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 185 Asia Pacific Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 186 Asia Pacific Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 187 Asia Pacific Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 188 Asia Pacific Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 189 Japan Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 190 Japan Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 191 Japan Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 192 Japan Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 193 Japan Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 194 China Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 195 China Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 196 China Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 197 China Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 198 China Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 199 India Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 200 India Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 201 India Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 202 India Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 203 India Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 204 Australia Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 205 Australia Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 206 Australia Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 207 Australia Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 208 Australia Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 209 South Korea Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 210 South Korea Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 211 South Korea Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 212 South Korea Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 213 South Korea Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 214 South-East Asia Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 215 South-East Asia Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 216 South-East Asia Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 217 South-East Asia Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 218 South-East Asia Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 219 Rest of Asia Pacific Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 220 Rest of Asia Pacific Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 221 Rest of Asia Pacific Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 222 Rest of Asia Pacific Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 223 Rest of Asia Pacific Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 224 Latin America Anti-Obesity Drugs Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 225 Latin America Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 226 Latin America Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 227 Latin America Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 228 Latin America Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 229 Latin America Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 230 Latin America Anti-Obesity Drugs Market Forecast by Prescription, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 231 Latin America Anti-Obesity Drugs Market Forecast by Prescription, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 232 Latin America Anti-Obesity Drugs Market Forecast by Prescription, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 233 Latin America Anti-Obesity Drugs Market Forecast by Prescription, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 234 Latin America Anti-Obesity Drugs Market Forecast by Prescription, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 235 Latin America Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 236 Latin America Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 237 Latin America Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 238 Latin America Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 239 Latin America Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 240 Latin America Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 241 Latin America Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 242 Latin America Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 243 Latin America Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 244 Latin America Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 245 Brazil Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 246 Brazil Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 247 Brazil Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 248 Brazil Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 249 Brazil Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 250 Mexico Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 251 Mexico Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 252 Mexico Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 253 Mexico Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 254 Mexico Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 255 Rest of Latin America Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 256 Rest of Latin America Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 257 Rest of Latin America Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 258 Rest of Latin America Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 259 Rest of Latin America Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 260 MEA Anti-Obesity Drugs Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 261 MEA Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 262 MEA Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 263 MEA Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 264 MEA Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 265 MEA Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 266 MEA Anti-Obesity Drugs Market Forecast by Prescription, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 267 MEA Anti-Obesity Drugs Market Forecast by Prescription, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 268 MEA Anti-Obesity Drugs Market Forecast by Prescription, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 269 MEA Anti-Obesity Drugs Market Forecast by Prescription, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 270 MEA Anti-Obesity Drugs Market Forecast by Prescription, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 271 MEA Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 272 MEA Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 273 MEA Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 274 MEA Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 275 MEA Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 276 MEA Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 277 MEA Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 278 MEA Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 279 MEA Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 280 MEA Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 281 GCC Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 282 GCC Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 283 GCC Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 284 GCC Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 285 GCC Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 286 South Africa Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 287 South Africa Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 288 South Africa Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 289 South Africa Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 290 South Africa Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 291 Rest of MEA Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 292 Rest of MEA Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 293 Rest of MEA Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 294 Rest of MEA Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 295 Rest of MEA Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 296 Bristol-Myers Squibb: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 297 Bristol-Myers Squibb: Product Benchmarking
Table 298 Bristol-Myers Squibb: Recent Developments
Table 299 Currax Pharmaceuticals LLC: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 300 Currax Pharmaceuticals LLC: Product Benchmarking
Table 301 Currax Pharmaceuticals LLC: Recent Developments
Table 302 Eisai Co. Ltd: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 303 Eisai Co. Ltd: Product Benchmarking
Table 304 Eisai Co. Ltd: Recent Developments
Table 305 GlaxoSmithKline PLC: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 306 GlaxoSmithKline PLC: Product Benchmarking
Table 307 GlaxoSmithKline PLC: Recent Developments
Table 308 Merck & Co. Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 309 Merck & Co. Inc.: Product Benchmarking
Table 310 Merck & Co. Inc.: Recent Developments
Table 311 Novo Nordisk A/S: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 312 Novo Nordisk A/S: Product Benchmarking
Table 313 Novo Nordisk A/S: Recent Developments
Table 314 Pfizer Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 315 Pfizer Inc.: Product Benchmarking
Table 316 Pfizer Inc.: Recent Developments
Table 317 Rhythm Pharmaceuticals: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 318 Rhythm Pharmaceuticals: Product Benchmarking
Table 319 Rhythm Pharmaceuticals: Recent Developments
Table 320 Vivus Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 321 Vivus Inc.: Product Benchmarking
Table 322 Vivus Inc.: Recent Developments
Table 323 ERX Pharmaceuticals: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 324 ERX Pharmaceuticals: Product Benchmarking
Table 325 CohBar: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 326 CohBar: Product Benchmarking
Table 327 CohBar: Recent Developments
Table 328 Carmot Therapeutics: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 329 Carmot Therapeutics: Product Benchmarking
Table 330 YSOPIA Bioscience: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 331 YSOPIA Bioscience: Product Benchmarking
Table 332 Gelesis: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 333 Gelesis: Product Benchmarking
Table 334 Scohia Pharma, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 335 Scohia Pharma, Inc.: Product Benchmarking
Table 336 Hanmi Pharmaceutical, Co., Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 337 Hanmi Pharmaceutical, Co., Ltd.: Product Benchmarking
Table 338 Saniona: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 339 Saniona: Product Benchmarking
List of Figures
Figure 1 Global Anti-Obesity Drugs Market: Market Segmentation
Figure 2 Global Anti-Obesity Drugs Market Attractiveness Index
Figure 3 Global Anti-Obesity Drugs Market: DROC
Figure 4 Global Anti-Obesity Drugs Market: SWOT Analysis
Figure 5 Porter’s Analysis
Figure 6 PEST Analysis
Figure 7 Global Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR %)
Figure 8 Global Anti-Obesity Drugs Market Share Forecast by Mechanism of Action, 2021, 2026, 2031 (%)
Figure 9 Global Anti-Obesity Drugs Market for Incretin Mimetics/GLP-1 Agonists Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 10 Global Anti-Obesity Drugs Market for Incretin Mimetics/GLP-1 Agonists Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 11 Global Anti-Obesity Drugs Market for Incretin Mimetics/GLP-1 Agonists Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 12 Global Anti-Obesity Drugs Market for Incretin Mimetics/GLP-1 Agonists Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 13 Global Anti-Obesity Drugs Market for Incretin Mimetics/GLP-1 Agonists Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 14 Global Anti-Obesity Drugs Market for Lipase Inhibitors Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 15 Global Anti-Obesity Drugs Market for Lipase Inhibitors Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 16 Global Anti-Obesity Drugs Market for Lipase Inhibitors Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 17 Global Anti-Obesity Drugs Market for Lipase Inhibitors Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 18 Global Anti-Obesity Drugs Market for Lipase Inhibitors Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 19 Global Anti-Obesity Drugs Market for SNDRI’s Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 20 Global Anti-Obesity Drugs Market for SNDRI’s Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 21 Global Anti-Obesity Drugs Market for SNDRI’s Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 22 Global Anti-Obesity Drugs Market for SNDRI’s Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 23 Global Anti-Obesity Drugs Market for SNDRI’s Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 24 Global Anti-Obesity Drugs Market for Serotonin Receptor Agonists Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 25 Global Anti-Obesity Drugs Market for Serotonin Receptor Agonists Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 26 Global Anti-Obesity Drugs Market for Serotonin Receptor Agonists Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 27 Global Anti-Obesity Drugs Market for Serotonin Receptor Agonists Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 28 Global Anti-Obesity Drugs Market for Serotonin Receptor Agonists Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 29 Global Anti-Obesity Drugs Market for Sympathomimetic-GABA Receptor Agonists Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 30 Global Anti-Obesity Drugs Market for Sympathomimetic-GABA Receptor Agonists Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 31 Global Anti-Obesity Drugs Market for Sympathomimetic-GABA Receptor Agonists Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 32 Global Anti-Obesity Drugs Market for Sympathomimetic-GABA Receptor Agonists Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 33 Global Anti-Obesity Drugs Market for Sympathomimetic-GABA Receptor Agonists Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 34 Global Anti-Obesity Drugs Market for Sympathomimetics Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 35 Global Anti-Obesity Drugs Market for Sympathomimetics Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 36 Global Anti-Obesity Drugs Market for Sympathomimetics Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 37 Global Anti-Obesity Drugs Market for Sympathomimetics Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 38 Global Anti-Obesity Drugs Market for Sympathomimetics Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 39 Global Anti-Obesity Drugs Market for Others Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 40 Global Anti-Obesity Drugs Market for Others Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 41 Global Anti-Obesity Drugs Market for Others Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 42 Global Anti-Obesity Drugs Market for Others Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 43 Global Anti-Obesity Drugs Market for Others Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 44 Global Anti-Obesity Drugs Market Forecast by Type, 2021-2031 (US$ million, AGR %)
Figure 45 Global Anti-Obesity Drugs Market Share Forecast by Type, 2021, 2026, 2031 (%)
Figure 46 Global Anti-Obesity Drugs Market for Prescription Drugs Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 47 Global Anti-Obesity Drugs Market for Prescription Drugs Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 48 Global Anti-Obesity Drugs Market for Prescription Drugs Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 49 Global Anti-Obesity Drugs Market for Prescription Drugs Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 50 Global Anti-Obesity Drugs Market for Prescription Drugs Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 51 Global Anti-Obesity Drugs Market for OTC Drugs Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 52 Global Anti-Obesity Drugs Market for OTC Drugs Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 53 Global Anti-Obesity Drugs Market for OTC Drugs Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 54 Global Anti-Obesity Drugs Market for OTC Drugs Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 55 Global Anti-Obesity Drugs Market for OTC Drugs Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 56 Global Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR %)
Figure 57 Global Anti-Obesity Drugs Market Share Forecast by Duration, 2021, 2026, 2031 (%)
Figure 58 Global Anti-Obesity Drugs Market for Short-Term Anti-Obesity Drugs Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 59 Global Anti-Obesity Drugs Market for Short-Term Anti-Obesity Drugs Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 60 Global Anti-Obesity Drugs Market for Short-Term Anti-Obesity Drugs Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 61 Global Anti-Obesity Drugs Market for Short-Term Anti-Obesity Drugs Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 62 Global Anti-Obesity Drugs Market for Short-Term Anti-Obesity Drugs Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 63 Global Anti-Obesity Drugs Market for Long-Term Anti-Obesity Drugs Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 64 Global Anti-Obesity Drugs Market for Long-Term Anti-Obesity Drugs Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 65 Global Anti-Obesity Drugs Market for Long-Term Anti-Obesity Drugs Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 66 Global Anti-Obesity Drugs Market for Long-Term Anti-Obesity Drugs Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 67 Global Anti-Obesity Drugs Market for Long-Term Anti-Obesity Drugs Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 68 Global Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR %)
Figure 69 Global Anti-Obesity Drugs Market Share Forecast by Distribution Channel, 2021, 2026, 2031 (%)
Figure 70 Global Anti-Obesity Drugs Market for Hospitals Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 71 Global Anti-Obesity Drugs Market for Hospitals Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 72 Global Anti-Obesity Drugs Market for Hospitals Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 73 Global Anti-Obesity Drugs Market for Hospitals Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 74 Global Anti-Obesity Drugs Market for Hospitals Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 75 Global Anti-Obesity Drugs Market for Retail Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 76 Global Anti-Obesity Drugs Market for Retail Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 77 Global Anti-Obesity Drugs Market for Retail Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 78 Global Anti-Obesity Drugs Market for Retail Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 79 Global Anti-Obesity Drugs Market for Retail Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 80 Global Anti-Obesity Drugs Market for Online Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 81 Global Anti-Obesity Drugs Market for Online Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 82 Global Anti-Obesity Drugs Market for Online Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 83 Global Anti-Obesity Drugs Market for Online Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 84 Global Anti-Obesity Drugs Market for Online Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 85 Global Anti-Obesity Drugs Market Forecast by Region 2021-2031 (US$ million)
Figure 86 Global Anti-Obesity Drugs Market Share Forecast by Region 2021, 2026, 2031 (%)
Figure 87 Global Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 88 Global Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 89 Global Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 90 Global Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 91 North America Anti-Obesity Drugs Market Forecast by Country 2021-2031 (US$ million)
Figure 92 North America Anti-Obesity Drugs Market Share Forecast by Country 2021, 2026, 2031 (%)
Figure 93 North America Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%)
Figure 94 North America Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 95 North America Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 96 North America Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 97 North America Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 98 North America Anti-Obesity Drugs Market Forecast by Type, 2021-2031 (US$ million, AGR%)
Figure 99 North America Anti-Obesity Drugs Market Forecast by Type, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 100 North America Anti-Obesity Drugs Market Forecast by Type, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 101 North America Anti-Obesity Drugs Market Forecast by Type, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 102 North America Anti-Obesity Drugs Market Forecast by Type, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 103 North America Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%)
Figure 104 North America Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 105 North America Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 106 North America Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 107 North America Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 108 North America Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%)
Figure 109 North America Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 110 North America Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 111 North America Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 112 North America Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 113 U.S. Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 114 U.S. Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 115 U.S. Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 116 U.S. Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 117 U.S. Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 118 Canada Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 119 Canada Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 120 Canada Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 121 Canada Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 122 Canada Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 123 Europe Anti-Obesity Drugs Market Forecast by Country 2021-2031 (US$ million)
Figure 124 Europe Anti-Obesity Drugs Market Share Forecast by Country 2021, 2026, 2031 (%)
Figure 125 Europe Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%)
Figure 126 Europe Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 127 Europe Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 128 Europe Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 129 Europe Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 130 Europe Anti-Obesity Drugs Market Forecast by Type, 2021-2031 (US$ million, AGR%)
Figure 131 Europe Anti-Obesity Drugs Market Forecast by Type, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 132 Europe Anti-Obesity Drugs Market Forecast by Type, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 133 Europe Anti-Obesity Drugs Market Forecast by Type, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 134 Europe Anti-Obesity Drugs Market Forecast by Type, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 135 Europe Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%)
Figure 136 Europe Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 137 Europe Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 138 Europe Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 139 Europe Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 140 Europe Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%)
Figure 141 Europe Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 142 Europe Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 143 Europe Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 144 Europe Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 145 Germany Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 146 Germany Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 147 Germany Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 148 Germany Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 149 Germany Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 150 UK Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 151 UK Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 152 UK Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 153 UK Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 154 UK Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 155 France Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 156 France Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 157 France Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 158 France Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 159 France Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 160 Italy Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 161 Italy Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 162 Italy Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 163 Italy Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 164 Italy Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 165 Spain Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 166 Spain Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 167 Spain Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 168 Spain Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 169 Spain Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 170 Russia Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 171 Russia Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 172 Russia Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 173 Russia Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 174 Russia Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 175 Rest of Europe Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 176 Rest of Europe Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 177 Rest of Europe Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 178 Rest of Europe Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 179 Rest of Europe Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 180 Asia Pacific Anti-Obesity Drugs Market Forecast by Country 2021-2031 (US$ million)
Figure 181 Asia Pacific Anti-Obesity Drugs Market Share Forecast by Country 2021, 2026, 2031 (%)
Figure 182 Asia Pacific Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%)
Figure 183 Asia Pacific Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 184 Asia Pacific Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 185 Asia Pacific Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 186 Asia Pacific Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 187 Asia Pacific Anti-Obesity Drugs Market Forecast by Type, 2021-2031 (US$ million, AGR%)
Figure 188 Asia Pacific Anti-Obesity Drugs Market Forecast by Type, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 189 Asia Pacific Anti-Obesity Drugs Market Forecast by Type, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 190 Asia Pacific Anti-Obesity Drugs Market Forecast by Type, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 191 Asia Pacific Anti-Obesity Drugs Market Forecast by Type, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 192 Asia Pacific Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%)
Figure 193 Asia Pacific Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 194 Asia Pacific Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 195 Asia Pacific Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 196 Asia Pacific Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 197 Asia Pacific Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%)
Figure 198 Asia Pacific Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 199 Asia Pacific Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 200 Asia Pacific Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 201 Asia Pacific Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 202 Japan Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 203 Japan Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 204 Japan Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 205 Japan Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 206 Japan Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 207 China Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 208 China Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 209 China Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 210 China Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 211 China Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 212 India Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 213 India Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 214 India Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 215 India Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 216 India Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 217 Australia Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 218 Australia Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 219 Australia Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 220 Australia Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 221 Australia Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 222 South Korea Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 223 South Korea Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 224 South Korea Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 225 South Korea Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 226 South Korea Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 227 South-East Asia Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 228 South-East Asia Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 229 South-East Asia Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 230 South-East Asia Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 231 South-East Asia Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 232 Rest of Asia Pacific Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 233 Rest of Asia Pacific Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 234 Rest of Asia Pacific Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 235 Rest of Asia Pacific Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 236 Rest of Asia Pacific Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 237 Latin America Anti-Obesity Drugs Market Forecast by Country 2021-2031 (US$ million)
Figure 238 Latin America Anti-Obesity Drugs Market Share Forecast by Country 2021, 2026, 2031 (%)
Figure 239 Latin America Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%)
Figure 240 Latin America Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 241 Latin America Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 242 Latin America Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 243 Latin America Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 244 Latin America Anti-Obesity Drugs Market Forecast by Type, 2021-2031 (US$ million, AGR%)
Figure 245 Latin America Anti-Obesity Drugs Market Forecast by Type, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 246 Latin America Anti-Obesity Drugs Market Forecast by Type, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 247 Latin America Anti-Obesity Drugs Market Forecast by Type, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 248 Latin America Anti-Obesity Drugs Market Forecast by Type, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 249 Latin America Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%)
Figure 250 Latin America Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 251 Latin America Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 252 Latin America Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 253 Latin America Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 254 Latin America Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%)
Figure 255 Latin America Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 256 Latin America Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 257 Latin America Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 258 Latin America Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 259 Brazil Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 260 Brazil Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 261 Brazil Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 262 Brazil Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 263 Brazil Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 264 Mexico Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 265 Mexico Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 266 Mexico Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 267 Mexico Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 268 Mexico Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 269 Rest of Latin America Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 270 Rest of Latin America Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 271 Rest of Latin America Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 272 Rest of Latin America Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 273 Rest of Latin America Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 274 Middle East and Africa Anti-Obesity Drugs Market Forecast by Country 2021-2031 (US$ million)
Figure 275 Middle East and Africa Anti-Obesity Drugs Market Share Forecast by Country 2021, 2026, 2031 (%)
Figure 276 MEA Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%)
Figure 277 MEA Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 278 MEA Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 279 MEA Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 280 MEA Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 281 MEA Anti-Obesity Drugs Market Forecast by Type, 2021-2031 (US$ million, AGR%)
Figure 282 MEA Anti-Obesity Drugs Market Forecast by Type, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 283 MEA Anti-Obesity Drugs Market Forecast by Type, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 284 MEA Anti-Obesity Drugs Market Forecast by Type, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 285 MEA Anti-Obesity Drugs Market Forecast by Type, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 286 MEA Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%)
Figure 287 MEA Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 288 MEA Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 289 MEA Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 290 MEA Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 291 MEA Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%)
Figure 292 MEA Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 293 MEA Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 294 MEA Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 295 MEA Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 296 GCC Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 297 GCC Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 298 GCC Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 299 GCC Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 300 GCC Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 301 South Africa Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 302 South Africa Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 303 South Africa Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 304 South Africa Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 305 South Africa Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 306 Rest of Middle East and Africa Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 307 Rest of Middle East and Africa Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 308 Rest of Middle East and Africa Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 309 Rest of Middle East and Africa Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 310 Rest of Middle East and Africa Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 311 Bristol-Myers Squibb: Net Revenue, 2015-2020 (US$ million, AGR%)
Figure 312 Bristol-Myers Squibb: R&D Expenses, 2015-2020 (US$ million, AGR%)
Figure 313 Bristol-Myers Squibb: Gross Profit, 2015-2020 (US$ million, AGR%)
Figure 314 Eisai Co. Ltd: Net Revenue, 2015-2020 (US$ million, AGR%)
Figure 315 Eisai Co. Ltd: R&D Expenses, 2015-2020 (US$ million, AGR%)
Figure 316 Eisai Co. Ltd: Gross Profit, 2015-2020 (US$ million, AGR%)
Figure 317 GlaxoSmithKline PLC: Net Revenue, 2015-2020 (US$ million, AGR%)
Figure 318 GlaxoSmithKline PLC: R&D Expenses, 2015-2020 (US$ million, AGR%)
Figure 319 GlaxoSmithKline PLC: Gross Profit, 2015-2020 (US$ million, AGR%)
Figure 320 Merck & Co. Inc.: Net Revenue, 2015-2020 (US$ million, AGR%)
Figure 321 Merck & Co. Inc.: R&D Expenses, 2015-2020 (US$ million, AGR%)
Figure 322 Merck & Co. Inc.: Gross Profit, 2015-2020 (US$ million, AGR%)
Figure 323 Novo Nordisk A/S: Net Revenue, 2015-2020 (US$ million, AGR%)
Figure 324 Novo Nordisk A/S: R&D Expenses, 2015-2020 (US$ million, AGR%)
Figure 325 Novo Nordisk A/S: Gross Profit, 2015-2020 (US$ million, AGR%)
Figure 326 Pfizer Inc.: Net Revenue, 2015-2020 (US$ million, AGR%)
Figure 327 Pfizer Inc.: R&D Expenses, 2015-2020 (US$ million, AGR%)
Figure 328 Pfizer Inc.: Gross Profit, 2015-2020 (US$ million, AGR%)
Figure 329 Rhythm Pharmaceuticals: R&D Expenses, 2015-2020 (US$ million, AGR%)
Figure 330 Vivus Inc.: Net Revenue, 2015-2020 (US$ million, AGR%)
Figure 331 Vivus Inc.: R&D Expenses, 2015-2020 (US$ million, AGR%)
Figure 332 Vivus Inc.: Gross Profit, 2015-2020 (US$ million, AGR%)
Figure 333 CohBar: R&D Expenses, 2015-2020 (US$ million, AGR%)
Figure 334 Hanmi Pharmaceutical, Co., Ltd.: Net Revenue, 2015-2020 (US$ million, AGR%)
1.1 Introduction to Anti-Obesity Drugs Market
1.2 Anti-Obesity Drugs Market Definition
1.3 Why You Should Read This Report
1.4 What This Report Delivers
1.5 Key Questions Answered By This Analytical Report Include:
1.6 Who is This Report For?
1.7 Methodology
1.7.1 COVID-19 Impact: Recovery Scenarios
1.7.2 Market Evaluation & Forecasting Methodology
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain
2 Executive Summary
3 Market Dynamics
3.1 Drivers
3.1.1 Rising Obesity Awareness to Fuel Market Growth
3.1.2 Growing Healthcare Expenditure Anticipated to Drive Market Growth
3.2 Restraints
3.2.1 Lack of Understanding
3.2.2 Lack of Insurance to Restrain Market Growth
3.2.3 Clinical Trial Enrolment Challenging Market Growth
3.3 Opportunities
3.3.1 Growing Obesity Consciousness Among Public to Offer Lucrative Growth Opportunities
3.3.2 COVID-19 Pandemic Anticipated to Boost Market Growth
3.3.3 Emerging Economies to Offer Lucrative Growth Prospects
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weaknesses
3.4.3 Opportunities
3.4.4 Threats
3.5 Porter’s Five Forces Analysis
3.5.1 Buyer Power
3.5.2 Supplier Power
3.5.3 Competitive Rivalry
3.5.4 Threat of Substitute
3.5.5 Threat of New Entrants
3.6 PEST Analysis
3.6.1 Political Factors Impacting Anti-Obesity Drugs Market
3.6.2 Economic Factors Impacting Anti-Obesity Drugs Market
3.6.3 Social Factors Impacting Anti-Obesity Drugs Market
3.6.4 Technological Factors Impacting Anti-Obesity Drugs Market
4 Anti-Obesity Drugs Market by Mechanism of Action
4.1 Incretin Mimetics/GLP-1 Agonists Segment Market Forecast, 2021-2031
4.1.1 Incretin Mimetics/GLP-1 Agonists Market Overview
4.1.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
4.2 Lipase Inhibitors Segment Market Forecast, 2021-2031
4.2.1 Lipase Inhibitors Market Overview
4.2.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
4.3 SNDRI’s Segment Market Forecast, 2021-2031
4.3.1 SNDRI’s Market Overview
4.3.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
4.4 Serotonin Receptor Agonists Segment Market Forecast, 2021-2031
4.4.1 Serotonin Market Overview
4.4.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
4.5 Sympathomimetic-GABA Receptor Agonists Segment Market Forecast, 2021-2031
4.5.1 Sympathomimetic-GABA Receptor Agonists Market Revenue, 2021-2031
4.5.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
4.6 Sympathomimetics Segment Market Forecast, 2021-2031
4.6.1 Sympathomimetic Market Overview
4.6.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
4.7 Others Segment Market Forecast, 2021-2031
4.7.1 COVID-19 Impact Recovery Scenarios (V, U, W, L)
5 Anti-Obesity Drugs Market by Type
5.1 Prescription Drugs Segment Market Forecast, 2021-2031
5.1.1 Prescription Drugs Market Overview
5.1.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
5.2 OTC Drugs Segment Market Forecast, 2021-2031
5.2.1 OTC Drugs Market Overview
5.2.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
6 Anti-Obesity Drugs Market by Duration
6.1 Short-Term Anti-Obesity Drugs Segment Market Forecast, 2021-2031
6.1.1 Short-Term Anti-Obesity Drugs Market Overview
6.1.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
6.2 Long-Term Anti-Obesity Drugs Segment Market Forecast, 2021-2031
6.2.1 Long-Term Anti-Obesity Drugs Market Overview
6.2.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
7 Anti-Obesity Drugs Market by Distribution Channel
7.1 Hospitals Segment Market Forecast, 2021-2031
7.1.1 Hospitals Segment Market Overview
7.1.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
7.2 Retail Segment Market Forecast, 2021-2031
7.2.1 Retail Segment Market Overview
7.2.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
7.3 Online Segment Market Forecast, 2021-2031
7.3.1 Online Segment Market Overview
7.3.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
8 Regional and Leading National Anti-Obesity Drugs Market Forecasts 2021-2031
8.1 Global Anti-Obesity Drugs Market by Region Forecast 2021-2031
8.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
9 North America Anti-Obesity Drugs Market
9.1 North America Anti-Obesity Drugs Market by Country, Forecast 2021-2031
9.2 North America Anti-Obesity Drugs Market Forecast by Mechanism of Action
9.3 North America Anti-Obesity Drugs Market Forecast by Type
9.4 North America Anti-Obesity Drugs Market Forecast by Duration
9.5 North America Anti-Obesity Drugs Market Forecast by Distribution Channel
9.6 U.S. Anti-Obesity Drugs Market Forecast, 2021-2031
9.6.1 U.S. Anti-Obesity Drugs Market Overview
9.6.2 U.S. Anti-Obesity Drugs Market Forecast to 2031
9.6.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): U.S. Anti-Obesity Drugs Market Forecast, 2021-2031
9.7 Canada Anti-Obesity Drugs Market Forecast, 2021-2031
9.7.1 Canada Anti-Obesity Drugs Market Overview
9.7.2 Canada Anti-Obesity Drugs Market Forecast to 2031
9.7.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): Canada Anti-Obesity Drugs Market Forecast, 2021-2031
10 Europe Anti-Obesity Drugs Market
10.1 Europe Anti-Obesity Drugs Market by Country, Forecast 2021-2031
10.2 Europe Anti-Obesity Drugs Market Forecast by Mechanism of Action
10.3 Europe Anti-Obesity Drugs Market Forecast by Type
10.4 Europe Anti-Obesity Drugs Market Forecast by Duration
10.5 Europe Anti-Obesity Drugs Market Forecast by Distribution Channel
10.6 Germany Anti-Obesity Drugs Market Forecast, 2021-2031
10.6.1 Germany Anti-Obesity Drugs Market Overview
10.6.2 Germany Anti-Obesity Drugs Market Forecast to 2031
10.6.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): Germany Anti-Obesity Drugs Market Forecast, 2021-2031
10.7 UK Anti-Obesity Drugs Market Forecast, 2021-2031
10.7.1 UK Anti-Obesity Drugs Market Overview
10.7.2 UK Anti-Obesity Drugs Market Forecast to 2031
10.7.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): UK Anti-Obesity Drugs Market Forecast, 2021-2031
10.8 France Anti-Obesity Drugs Market Forecast, 2021-2031
10.8.1 France Anti-Obesity Drugs Market Overview
10.8.2 France Anti-Obesity Drugs Market Forecast to 2031
10.8.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): France Anti-Obesity Drugs Market Forecast, 2021-2031
10.9 Italy Anti-Obesity Drugs Market Forecast, 2021-2031
10.9.1 Italy Anti-Obesity Drugs Market Overview
10.9.2 Italy Anti-Obesity Drugs Market Forecast to 2031
10.9.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): Italy Anti-Obesity Drugs Market Forecast, 2021-2031
10.10 Spain Anti-Obesity Drugs Market Forecast, 2021-2031
10.10.1 Spain Anti-Obesity Drugs Market Overview
10.10.2 Spain Anti-Obesity Drugs Market Forecast to 2031
10.10.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): Spain Anti-Obesity Drugs Market Forecast, 2021-2031
10.11 Russia Anti-Obesity Drugs Market Forecast, 2021-2031
10.11.1 Russia Anti-Obesity Drugs Market Overview
10.11.2 Russia Anti-Obesity Drugs Market Forecast to 2031
10.11.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): Russia Anti-Obesity Drugs Market Forecast, 2021-2031
10.12 Rest of Europe Anti-Obesity Drugs Market Forecast, 2021-2031
10.12.1 Rest of Europe Anti-Obesity Drugs Market Overview
10.12.2 Rest of Europe Anti-Obesity Drugs Market Forecast to 2031
10.12.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): Rest of Europe Anti-Obesity Drugs Market Forecast, 2021-2031
11 Asia Pacific Anti-Obesity Drugs Market
11.1 Asia Pacific Anti-Obesity Drugs Market by Country, Forecast 2021-2031
11.2 Asia Pacific Anti-Obesity Drugs Market Forecast by Mechanism of Action
11.3 Asia Pacific Anti-Obesity Drugs Market Forecast by Type
11.4 Asia Pacific Anti-Obesity Drugs Market Forecast by Duration
11.5 Asia Pacific Anti-Obesity Drugs Market Forecast by Distribution Channel
11.6 Japan Anti-Obesity Drugs Market Forecast, 2021-2031
11.6.1 Japan Anti-Obesity Drugs Market Overview
11.6.2 Japan Anti-Obesity Drugs Market Forecast to 2031
11.6.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): Japan Anti-Obesity Drugs Market Forecast, 2021-2031
11.7 China Anti-Obesity Drugs Market Forecast, 2021-2031
11.7.1 China Anti-Obesity Drugs Market Overview
11.7.2 China Anti-Obesity Drugs Market Forecast to 2031
11.7.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): China Anti-Obesity Drugs Market Forecast, 2021-2031
11.8 India Anti-Obesity Drugs Market Forecast, 2021-2031
11.8.1 India Anti-Obesity Drugs Market Overview
11.8.2 India Anti-Obesity Drugs Market Forecast to 2031
11.8.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): India Anti-Obesity Drugs Market Forecast, 2021-2031
11.9 Australia Anti-Obesity Drugs Market Forecast, 2021-2031
11.9.1 Australia Anti-Obesity Drugs Market Overview
11.9.2 Australia Anti-Obesity Drugs Market Forecast to 2031
11.9.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): Australia Anti-Obesity Drugs Market Forecast, 2021-2031
11.10 South Korea Anti-Obesity Drugs Market Forecast, 2021-2031
11.10.1 South Korea Anti-Obesity Drugs Market Overview
11.10.2 South Korea Anti-Obesity Drugs Market Forecast to 2031
11.10.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): South Korea Anti-Obesity Drugs Market Forecast, 2021-2031
11.11 South-East Asia Anti-Obesity Drugs Market Forecast, 2021-2031
11.11.1 South-East Asia Anti-Obesity Drugs Market Forecast to 2031
11.11.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): South-East Asia Anti-Obesity Drugs Market Forecast, 2021-2031
11.12 Rest of Asia Pacific Anti-Obesity Drugs Market Forecast, 2021-2031
11.12.1 Rest of Asia Pacific Anti-Obesity Drugs Market Forecast to 2031
11.12.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): Rest of Asia Pacific Anti-Obesity Drugs Market Forecast, 2021-2031
12 Latin America Anti-Obesity Drugs Market
12.1 Latin America Anti-Obesity Drugs Market by Country, Forecast 2021-2031
12.2 Latin America Anti-Obesity Drugs Market Forecast by Mechanism of Action
12.3 Latin America Anti-Obesity Drugs Market Forecast by Type
12.4 Latin America Anti-Obesity Drugs Market Forecast by Duration
12.5 Latin America Anti-Obesity Drugs Market Forecast by Distribution Channel
12.6 Brazil Anti-Obesity Drugs Market Forecast, 2021-2031
12.6.1 Brazil Anti-Obesity Drugs Market Overview
12.6.2 Brazil Anti-Obesity Drugs Market Forecast to 2031
12.6.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): Brazil Anti-Obesity Drugs Market Forecast, 2021-2031
12.7 Mexico Anti-Obesity Drugs Market Forecast, 2021-2031
12.7.1 Mexico Anti-Obesity Drugs Market Overview
12.7.2 Mexico Anti-Obesity Drugs Market Forecast to 2031
12.7.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): Mexico Anti-Obesity Drugs Market Forecast, 2021-2031
12.8 Rest of Latin America Anti-Obesity Drugs Market Forecast, 2021-2031
12.8.1 Rest of Latin America Anti-Obesity Drugs Market Forecast to 2031
12.8.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): Rest of Latin America Anti-Obesity Drugs Market Forecast, 2021-2031
13 Middle East and Africa Anti-Obesity Drugs Market
13.1 Middle East and Africa Anti-Obesity Drugs Market by Country, Forecast 2021-2031
13.2 MEA Anti-Obesity Drugs Market Forecast by Mechanism of Action
13.3 MEA Anti-Obesity Drugs Market Forecast by Type
13.4 MEA Anti-Obesity Drugs Market Forecast by Duration
13.5 MEA Anti-Obesity Drugs Market Forecast by Distribution Channel
13.6 GCC Anti-Obesity Drugs Market Forecast, 2021-2031
13.6.1 GCC Anti-Obesity Drugs Market Overview
13.6.2 GCC Anti-Obesity Drugs Market Forecast to 2031
13.6.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): GCC Anti-Obesity Drugs Market Forecast, 2021-2031
13.7 South Africa Anti-Obesity Drugs Market Forecast, 2021-2031
13.7.1 South Africa Anti-Obesity Drugs Market Overview
13.7.2 South Africa Anti-Obesity Drugs Market Forecast to 2031
13.7.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): South Africa Anti-Obesity Drugs Market Forecast, 2021-2031
13.8 Rest of Middle East and Africa Anti-Obesity Drugs Market Forecast, 2021-2031
13.8.1 Rest of MEA Anti-Obesity Drugs Market Overview
13.8.2 Rest of MEA Anti-Obesity Drugs Market Forecast to 2031
13.8.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): Rest of Middle East and Africa Anti-Obesity Drugs Market Forecast, 2021-2031
14 Company Profiles
14.1 Bristol-Myers Squibb
14.1.1 Company Snapshot
14.1.2 Company Overview
14.1.3 Financial Analysis
14.1.4 Product Benchmarking
14.1.5 Recent Developments
14.2 Currax Pharmaceuticals LLC
14.2.1 Company Snapshot
14.2.2 Company Overview
14.2.3 Product Benchmarking
14.2.4 Recent Developments
14.3 Eisai Co. Ltd
14.3.1 Company Snapshot
14.3.2 Company Overview
14.3.3 Financial Analysis
14.3.4 Product Benchmarking
14.3.5 Recent Developments
14.4 GlaxoSmithKline PLC
14.4.1 Company Snapshot
14.4.2 Company Overview
14.4.3 Financial Analysis
14.4.4 Product Benchmarking
14.4.5 Recent Developments
14.5 Merck & Co. Inc.
14.5.1 Company Snapshot
14.5.2 Company Overview
14.5.3 Financial Analysis
14.5.4 Product Benchmarking
14.5.5 Recent Developments
14.6 Novo Nordisk A/S
14.6.1 Company Snapshot
14.6.2 Company Overview
14.6.3 Financial Analysis
14.6.4 Product Benchmarking
14.6.5 Recent Developments
14.7 Pfizer Inc.
14.7.1 Company Snapshot
14.7.2 Company Overview
14.7.3 Financial Analysis
14.7.4 Product Benchmarking
14.7.5 Recent Developments
14.8 Rhythm Pharmaceuticals
14.8.1 Company Snapshot
14.8.2 Company Overview
14.8.3 Financial Analysis
14.8.4 Product Benchmarking
14.8.5 Recent Developments
14.9 Vivus Inc.
14.9.1 Company Snapshot
14.9.2 Company Overview
14.9.3 Financial Analysis
14.9.4 Product Benchmarking
14.9.5 Recent Developments
14.10 ERX Pharmaceuticals
14.10.1 Company Snapshot
14.10.2 Company Overview
14.10.3 Product Benchmarking
14.11 CohBar
14.11.1 Company Snapshot
14.11.2 Company Overview
14.11.3 Financial Analysis
14.11.4 Product Benchmarking
Recent Developments
14.12 Carmot Therapeutics
14.12.1 Company Snapshot
14.12.2 Company Overview
14.12.3 Product Benchmarking
14.13 YSOPIA Bioscience
14.13.1 Company Snapshot
14.13.2 Company Overview
14.13.3 Product Benchmarking
14.14 Gelesis
14.14.1 Company Snapshot
14.14.2 Company Overview
14.14.3 Product Benchmarking
14.15 Scohia Pharma, Inc.
14.15.1 Company Snapshot
14.15.2 Company Overview
14.15.3 Product Benchmarking
14.16 Hanmi Pharmaceutical, Co., Ltd.
14.16.1 Company Snapshot
14.16.2 Company Overview
14.16.3 Financial Analysis
14.16.4 Product Benchmarking
14.17 Saniona
14.17.1 Company Snapshot
14.17.2 Company Overview
14.17.3 Product Benchmarking
15 Conclusion and Recommendations
15.1 Concluding Remarks
15.2 Recommendations for Market Players
List of Tables
Table 1 Global Anti-Obesity Drugs Market Snapshot, 2021 & 2031 (US$ million, CAGR %)
Table 2 Global Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 3 Global Anti-Obesity Drugs Market Forecast for Incretin Mimetics/GLP-1 Agonists Segment, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 4 Global Anti-Obesity Drugs Market Forecast for Incretin Mimetics/GLP-1 Agonists Segment, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 5 Global Anti-Obesity Drugs Market Forecast for Incretin Mimetics/GLP-1 Agonists Segment, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 6 Global Anti-Obesity Drugs Market Forecast for Incretin Mimetics/GLP-1 Agonists Segment, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 7 Global Anti-Obesity Drugs Market Forecast for Incretin Mimetics/GLP-1 Agonists Segment, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 8 Global Anti-Obesity Drugs Market Forecast for Lipase Inhibitors Segment, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 9 Global Anti-Obesity Drugs Market Forecast for Lipase Inhibitors Segment, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 10 Global Anti-Obesity Drugs Market Forecast for Lipase Inhibitors Segment, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 11 Global Anti-Obesity Drugs Market Forecast for Lipase Inhibitors Segment, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 12 Global Anti-Obesity Drugs Market Forecast for Lipase Inhibitors Segment, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 13 Global Anti-Obesity Drugs Market Forecast for SNDRI's Segment, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 14 Global Anti-Obesity Drugs Market Forecast for SNDRI's Segment, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 15 Global Anti-Obesity Drugs Market Forecast for SNDRI's Segment, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 16 Global Anti-Obesity Drugs Market Forecast for SNDRI's Segment, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 17 Global Anti-Obesity Drugs Market Forecast for SNDRI's Segment, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 18 Global Anti-Obesity Drugs Market Forecast for Serotonin Receptor Agonists Segment, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 19 Global Anti-Obesity Drugs Market Forecast for Serotonin Receptor Agonists Segment, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 20 Global Anti-Obesity Drugs Market Forecast for Serotonin Receptor Agonists Segment, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 21 Global Anti-Obesity Drugs Market Forecast for Serotonin Receptor Agonists Segment, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 22 Global Anti-Obesity Drugs Market Forecast for Serotonin Receptor Agonists Segment, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 23 Global Anti-Obesity Drugs Market Forecast for Sympathomimetic-GABA Receptor Agonists Segment, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 24 Global Anti-Obesity Drugs Market Forecast for Sympathomimetic-GABA Receptor Agonists Segment, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 25 Global Anti-Obesity Drugs Market Forecast for Sympathomimetic-GABA Receptor Agonists Segment, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 26 Global Anti-Obesity Drugs Market Forecast for Sympathomimetic-GABA Receptor Agonists Segment, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 27 Global Anti-Obesity Drugs Market Forecast for Sympathomimetic-GABA Receptor Agonists Segment, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 28 Global Anti-Obesity Drugs Market Forecast for Sympathomimetics Segment, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 29 Global Anti-Obesity Drugs Market Forecast for Sympathomimetics Segment, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 30 Global Anti-Obesity Drugs Market Forecast for Sympathomimetics Segment, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 31 Global Anti-Obesity Drugs Market Forecast for Sympathomimetics Segment, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 32 Global Anti-Obesity Drugs Market Forecast for Sympathomimetics Segment, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 33 Global Anti-Obesity Drugs Market Forecast for Others Segment, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 34 Global Anti-Obesity Drugs Market Forecast for Others Segment, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 35 Global Anti-Obesity Drugs Market Forecast for Others Segment, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 36 Global Anti-Obesity Drugs Market Forecast for Others Segment, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 37 Global Anti-Obesity Drugs Market Forecast for Others Segment, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 38 Global Anti-Obesity Drugs Market Forecast by Prescription, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 39 Global Anti-Obesity Drugs Market Forecast for Prescription Drugs Segment, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 40 Global Anti-Obesity Drugs Market Forecast for Prescription Drugs Segment, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 41 Global Anti-Obesity Drugs Market Forecast for Prescription Drugs Segment, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 42 Global Anti-Obesity Drugs Market Forecast for Prescription Drugs Segment, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 43 Global Anti-Obesity Drugs Market Forecast for Prescription Drugs Segment, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 44 Global Anti-Obesity Drugs Market Forecast for OTC Drugs Segment, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 45 Global Anti-Obesity Drugs Market Forecast for OTC Drugs Segment, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 46 Global Anti-Obesity Drugs Market Forecast for OTC Drugs Segment, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 47 Global Anti-Obesity Drugs Market Forecast for OTC Drugs Segment, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 48 Global Anti-Obesity Drugs Market Forecast for OTC Drugs Segment, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 49 Global Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 50 Global Anti-Obesity Drugs Market Forecast for Short-Term Anti-Obesity Drugs Segment, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 51 Global Anti-Obesity Drugs Market Forecast for Short-Term Anti-Obesity Drugs Segment, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 52 Global Anti-Obesity Drugs Market Forecast for Short-Term Anti-Obesity Drugs Segment, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 53 Global Anti-Obesity Drugs Market Forecast for Short-Term Anti-Obesity Drugs Segment, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 54 Global Anti-Obesity Drugs Market Forecast for Short-Term Anti-Obesity Drugs Segment, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 55 Global Anti-Obesity Drugs Market Forecast for Long-Term Anti-Obesity Drugs Segment, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 56 Global Anti-Obesity Drugs Market Forecast for Long-Term Anti-Obesity Drugs Segment, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 57 Global Anti-Obesity Drugs Market Forecast for Long-Term Anti-Obesity Drugs Segment, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 58 Global Anti-Obesity Drugs Market Forecast for Long-Term Anti-Obesity Drugs Segment, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 59 Global Anti-Obesity Drugs Market Forecast for Long-Term Anti-Obesity Drugs Segment, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 60 Global Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 61 Global Anti-Obesity Drugs Market Forecast for Hospitals Segment, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 62 Global Anti-Obesity Drugs Market Forecast for Hospitals Segment, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 63 Global Anti-Obesity Drugs Market Forecast for Hospitals Segment, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 64 Global Anti-Obesity Drugs Market Forecast for Hospitals Segment, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 65 Global Anti-Obesity Drugs Market Forecast for Hospitals Segment, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 66 Global Anti-Obesity Drugs Market Forecast for Retail Segment, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 67 Global Anti-Obesity Drugs Market Forecast for Retail Segment, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 68 Global Anti-Obesity Drugs Market Forecast for Retail Segment, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 69 Global Anti-Obesity Drugs Market Forecast for Retail Segment, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 70 Global Anti-Obesity Drugs Market Forecast for Retail Segment, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 71 Global Anti-Obesity Drugs Market Forecast for Online Segment, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 72 Global Anti-Obesity Drugs Market Forecast for Online Segment, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 73 Global Anti-Obesity Drugs Market Forecast for Online Segment, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 74 Global Anti-Obesity Drugs Market Forecast for Online Segment, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 75 Global Anti-Obesity Drugs Market Forecast for Online Segment, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 76 Global Anti-Obesity Drugs Market Forecast by Region 2021-2031 (US$ mn, AGR%, CAGR%)
Table 77 Global Anti-Obesity Drugs Market Forecast by Region 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 78 Global Anti-Obesity Drugs Market Forecast by Region 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 79 Global Anti-Obesity Drugs Market Forecast by Region 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 80 Global Anti-Obesity Drugs Market Forecast by Region 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 81 North America Anti-Obesity Drugs Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 82 North America Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 83 North America Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 84 North America Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 85 North America Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 86 North America Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 87 North America Anti-Obesity Drugs Market Forecast by Prescription, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 88 North America Anti-Obesity Drugs Market Forecast by Prescription, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 89 North America Anti-Obesity Drugs Market Forecast by Prescription, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 90 North America Anti-Obesity Drugs Market Forecast by Prescription, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 91 North America Anti-Obesity Drugs Market Forecast by Prescription, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 92 North America Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 93 North America Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 94 North America Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 95 North America Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 96 North America Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 97 North America Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 98 North America Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 99 North America Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 100 North America Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 101 North America Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 102 U.S. Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 103 U.S. Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 104 U.S. Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 105 U.S. Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 106 U.S. Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 107 Canada Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 108 Canada Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 109 Canada Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 110 Canada Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 111 Canada Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 112 Europe Anti-Obesity Drugs Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 113 Europe Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 114 Europe Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 115 Europe Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 116 Europe Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 117 Europe Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 118 Europe Anti-Obesity Drugs Market Forecast by Prescription, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 119 Europe Anti-Obesity Drugs Market Forecast by Prescription, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 120 Europe Anti-Obesity Drugs Market Forecast by Prescription, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 121 Europe Anti-Obesity Drugs Market Forecast by Prescription, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 122 Europe Anti-Obesity Drugs Market Forecast by Prescription, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 123 Europe Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 124 Europe Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 125 Europe Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 126 Europe Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 127 Europe Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 128 Europe Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 129 Europe Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 130 Europe Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 131 Europe Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 132 Europe Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 133 Germany Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 134 Germany Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 135 Germany Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 136 Germany Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 137 Germany Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 138 UK Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 139 UK Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 140 UK Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 141 UK Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 142 UK Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 143 France Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 144 France Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 145 France Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 146 France Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 147 France Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 148 Italy Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 149 Italy Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 150 Italy Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 151 Italy Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 152 Italy Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 153 Spain Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 154 Spain Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 155 Spain Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 156 Spain Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 157 Spain Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 158 Russia Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 159 Russia Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 160 Russia Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 161 Russia Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 162 Russia Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 163 Rest of Europe Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 164 Rest of Europe Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 165 Rest of Europe Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 166 Rest of Europe Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 167 Rest of Europe Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 168 Asia Pacific Anti-Obesity Drugs Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 169 Asia Pacific Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 170 Asia Pacific Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 171 Asia Pacific Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 172 Asia Pacific Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 173 Asia Pacific Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 174 Asia Pacific Anti-Obesity Drugs Market Forecast by Prescription, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 175 Asia Pacific Anti-Obesity Drugs Market Forecast by Prescription, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 176 Asia Pacific Anti-Obesity Drugs Market Forecast by Prescription, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 177 Asia Pacific Anti-Obesity Drugs Market Forecast by Prescription, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 178 Asia Pacific Anti-Obesity Drugs Market Forecast by Prescription, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 179 Asia Pacific Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 180 Asia Pacific Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 181 Asia Pacific Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 182 Asia Pacific Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 183 Asia Pacific Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 184 Asia Pacific Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 185 Asia Pacific Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 186 Asia Pacific Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 187 Asia Pacific Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 188 Asia Pacific Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 189 Japan Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 190 Japan Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 191 Japan Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 192 Japan Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 193 Japan Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 194 China Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 195 China Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 196 China Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 197 China Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 198 China Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 199 India Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 200 India Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 201 India Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 202 India Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 203 India Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 204 Australia Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 205 Australia Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 206 Australia Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 207 Australia Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 208 Australia Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 209 South Korea Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 210 South Korea Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 211 South Korea Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 212 South Korea Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 213 South Korea Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 214 South-East Asia Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 215 South-East Asia Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 216 South-East Asia Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 217 South-East Asia Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 218 South-East Asia Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 219 Rest of Asia Pacific Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 220 Rest of Asia Pacific Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 221 Rest of Asia Pacific Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 222 Rest of Asia Pacific Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 223 Rest of Asia Pacific Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 224 Latin America Anti-Obesity Drugs Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 225 Latin America Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 226 Latin America Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 227 Latin America Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 228 Latin America Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 229 Latin America Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 230 Latin America Anti-Obesity Drugs Market Forecast by Prescription, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 231 Latin America Anti-Obesity Drugs Market Forecast by Prescription, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 232 Latin America Anti-Obesity Drugs Market Forecast by Prescription, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 233 Latin America Anti-Obesity Drugs Market Forecast by Prescription, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 234 Latin America Anti-Obesity Drugs Market Forecast by Prescription, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 235 Latin America Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 236 Latin America Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 237 Latin America Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 238 Latin America Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 239 Latin America Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 240 Latin America Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 241 Latin America Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 242 Latin America Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 243 Latin America Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 244 Latin America Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 245 Brazil Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 246 Brazil Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 247 Brazil Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 248 Brazil Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 249 Brazil Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 250 Mexico Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 251 Mexico Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 252 Mexico Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 253 Mexico Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 254 Mexico Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 255 Rest of Latin America Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 256 Rest of Latin America Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 257 Rest of Latin America Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 258 Rest of Latin America Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 259 Rest of Latin America Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 260 MEA Anti-Obesity Drugs Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 261 MEA Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 262 MEA Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 263 MEA Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 264 MEA Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 265 MEA Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 266 MEA Anti-Obesity Drugs Market Forecast by Prescription, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 267 MEA Anti-Obesity Drugs Market Forecast by Prescription, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 268 MEA Anti-Obesity Drugs Market Forecast by Prescription, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 269 MEA Anti-Obesity Drugs Market Forecast by Prescription, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 270 MEA Anti-Obesity Drugs Market Forecast by Prescription, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 271 MEA Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 272 MEA Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 273 MEA Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 274 MEA Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 275 MEA Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 276 MEA Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 277 MEA Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 278 MEA Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 279 MEA Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 280 MEA Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 281 GCC Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 282 GCC Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 283 GCC Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 284 GCC Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 285 GCC Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 286 South Africa Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 287 South Africa Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 288 South Africa Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 289 South Africa Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 290 South Africa Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 291 Rest of MEA Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 292 Rest of MEA Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 293 Rest of MEA Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 294 Rest of MEA Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 295 Rest of MEA Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 296 Bristol-Myers Squibb: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 297 Bristol-Myers Squibb: Product Benchmarking
Table 298 Bristol-Myers Squibb: Recent Developments
Table 299 Currax Pharmaceuticals LLC: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 300 Currax Pharmaceuticals LLC: Product Benchmarking
Table 301 Currax Pharmaceuticals LLC: Recent Developments
Table 302 Eisai Co. Ltd: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 303 Eisai Co. Ltd: Product Benchmarking
Table 304 Eisai Co. Ltd: Recent Developments
Table 305 GlaxoSmithKline PLC: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 306 GlaxoSmithKline PLC: Product Benchmarking
Table 307 GlaxoSmithKline PLC: Recent Developments
Table 308 Merck & Co. Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 309 Merck & Co. Inc.: Product Benchmarking
Table 310 Merck & Co. Inc.: Recent Developments
Table 311 Novo Nordisk A/S: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 312 Novo Nordisk A/S: Product Benchmarking
Table 313 Novo Nordisk A/S: Recent Developments
Table 314 Pfizer Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 315 Pfizer Inc.: Product Benchmarking
Table 316 Pfizer Inc.: Recent Developments
Table 317 Rhythm Pharmaceuticals: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 318 Rhythm Pharmaceuticals: Product Benchmarking
Table 319 Rhythm Pharmaceuticals: Recent Developments
Table 320 Vivus Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 321 Vivus Inc.: Product Benchmarking
Table 322 Vivus Inc.: Recent Developments
Table 323 ERX Pharmaceuticals: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 324 ERX Pharmaceuticals: Product Benchmarking
Table 325 CohBar: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 326 CohBar: Product Benchmarking
Table 327 CohBar: Recent Developments
Table 328 Carmot Therapeutics: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 329 Carmot Therapeutics: Product Benchmarking
Table 330 YSOPIA Bioscience: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 331 YSOPIA Bioscience: Product Benchmarking
Table 332 Gelesis: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 333 Gelesis: Product Benchmarking
Table 334 Scohia Pharma, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 335 Scohia Pharma, Inc.: Product Benchmarking
Table 336 Hanmi Pharmaceutical, Co., Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 337 Hanmi Pharmaceutical, Co., Ltd.: Product Benchmarking
Table 338 Saniona: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 339 Saniona: Product Benchmarking
List of Figures
Figure 1 Global Anti-Obesity Drugs Market: Market Segmentation
Figure 2 Global Anti-Obesity Drugs Market Attractiveness Index
Figure 3 Global Anti-Obesity Drugs Market: DROC
Figure 4 Global Anti-Obesity Drugs Market: SWOT Analysis
Figure 5 Porter’s Analysis
Figure 6 PEST Analysis
Figure 7 Global Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR %)
Figure 8 Global Anti-Obesity Drugs Market Share Forecast by Mechanism of Action, 2021, 2026, 2031 (%)
Figure 9 Global Anti-Obesity Drugs Market for Incretin Mimetics/GLP-1 Agonists Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 10 Global Anti-Obesity Drugs Market for Incretin Mimetics/GLP-1 Agonists Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 11 Global Anti-Obesity Drugs Market for Incretin Mimetics/GLP-1 Agonists Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 12 Global Anti-Obesity Drugs Market for Incretin Mimetics/GLP-1 Agonists Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 13 Global Anti-Obesity Drugs Market for Incretin Mimetics/GLP-1 Agonists Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 14 Global Anti-Obesity Drugs Market for Lipase Inhibitors Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 15 Global Anti-Obesity Drugs Market for Lipase Inhibitors Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 16 Global Anti-Obesity Drugs Market for Lipase Inhibitors Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 17 Global Anti-Obesity Drugs Market for Lipase Inhibitors Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 18 Global Anti-Obesity Drugs Market for Lipase Inhibitors Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 19 Global Anti-Obesity Drugs Market for SNDRI’s Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 20 Global Anti-Obesity Drugs Market for SNDRI’s Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 21 Global Anti-Obesity Drugs Market for SNDRI’s Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 22 Global Anti-Obesity Drugs Market for SNDRI’s Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 23 Global Anti-Obesity Drugs Market for SNDRI’s Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 24 Global Anti-Obesity Drugs Market for Serotonin Receptor Agonists Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 25 Global Anti-Obesity Drugs Market for Serotonin Receptor Agonists Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 26 Global Anti-Obesity Drugs Market for Serotonin Receptor Agonists Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 27 Global Anti-Obesity Drugs Market for Serotonin Receptor Agonists Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 28 Global Anti-Obesity Drugs Market for Serotonin Receptor Agonists Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 29 Global Anti-Obesity Drugs Market for Sympathomimetic-GABA Receptor Agonists Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 30 Global Anti-Obesity Drugs Market for Sympathomimetic-GABA Receptor Agonists Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 31 Global Anti-Obesity Drugs Market for Sympathomimetic-GABA Receptor Agonists Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 32 Global Anti-Obesity Drugs Market for Sympathomimetic-GABA Receptor Agonists Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 33 Global Anti-Obesity Drugs Market for Sympathomimetic-GABA Receptor Agonists Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 34 Global Anti-Obesity Drugs Market for Sympathomimetics Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 35 Global Anti-Obesity Drugs Market for Sympathomimetics Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 36 Global Anti-Obesity Drugs Market for Sympathomimetics Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 37 Global Anti-Obesity Drugs Market for Sympathomimetics Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 38 Global Anti-Obesity Drugs Market for Sympathomimetics Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 39 Global Anti-Obesity Drugs Market for Others Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 40 Global Anti-Obesity Drugs Market for Others Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 41 Global Anti-Obesity Drugs Market for Others Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 42 Global Anti-Obesity Drugs Market for Others Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 43 Global Anti-Obesity Drugs Market for Others Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 44 Global Anti-Obesity Drugs Market Forecast by Type, 2021-2031 (US$ million, AGR %)
Figure 45 Global Anti-Obesity Drugs Market Share Forecast by Type, 2021, 2026, 2031 (%)
Figure 46 Global Anti-Obesity Drugs Market for Prescription Drugs Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 47 Global Anti-Obesity Drugs Market for Prescription Drugs Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 48 Global Anti-Obesity Drugs Market for Prescription Drugs Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 49 Global Anti-Obesity Drugs Market for Prescription Drugs Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 50 Global Anti-Obesity Drugs Market for Prescription Drugs Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 51 Global Anti-Obesity Drugs Market for OTC Drugs Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 52 Global Anti-Obesity Drugs Market for OTC Drugs Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 53 Global Anti-Obesity Drugs Market for OTC Drugs Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 54 Global Anti-Obesity Drugs Market for OTC Drugs Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 55 Global Anti-Obesity Drugs Market for OTC Drugs Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 56 Global Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR %)
Figure 57 Global Anti-Obesity Drugs Market Share Forecast by Duration, 2021, 2026, 2031 (%)
Figure 58 Global Anti-Obesity Drugs Market for Short-Term Anti-Obesity Drugs Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 59 Global Anti-Obesity Drugs Market for Short-Term Anti-Obesity Drugs Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 60 Global Anti-Obesity Drugs Market for Short-Term Anti-Obesity Drugs Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 61 Global Anti-Obesity Drugs Market for Short-Term Anti-Obesity Drugs Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 62 Global Anti-Obesity Drugs Market for Short-Term Anti-Obesity Drugs Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 63 Global Anti-Obesity Drugs Market for Long-Term Anti-Obesity Drugs Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 64 Global Anti-Obesity Drugs Market for Long-Term Anti-Obesity Drugs Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 65 Global Anti-Obesity Drugs Market for Long-Term Anti-Obesity Drugs Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 66 Global Anti-Obesity Drugs Market for Long-Term Anti-Obesity Drugs Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 67 Global Anti-Obesity Drugs Market for Long-Term Anti-Obesity Drugs Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 68 Global Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR %)
Figure 69 Global Anti-Obesity Drugs Market Share Forecast by Distribution Channel, 2021, 2026, 2031 (%)
Figure 70 Global Anti-Obesity Drugs Market for Hospitals Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 71 Global Anti-Obesity Drugs Market for Hospitals Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 72 Global Anti-Obesity Drugs Market for Hospitals Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 73 Global Anti-Obesity Drugs Market for Hospitals Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 74 Global Anti-Obesity Drugs Market for Hospitals Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 75 Global Anti-Obesity Drugs Market for Retail Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 76 Global Anti-Obesity Drugs Market for Retail Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 77 Global Anti-Obesity Drugs Market for Retail Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 78 Global Anti-Obesity Drugs Market for Retail Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 79 Global Anti-Obesity Drugs Market for Retail Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 80 Global Anti-Obesity Drugs Market for Online Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 81 Global Anti-Obesity Drugs Market for Online Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 82 Global Anti-Obesity Drugs Market for Online Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 83 Global Anti-Obesity Drugs Market for Online Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 84 Global Anti-Obesity Drugs Market for Online Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 85 Global Anti-Obesity Drugs Market Forecast by Region 2021-2031 (US$ million)
Figure 86 Global Anti-Obesity Drugs Market Share Forecast by Region 2021, 2026, 2031 (%)
Figure 87 Global Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 88 Global Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 89 Global Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 90 Global Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 91 North America Anti-Obesity Drugs Market Forecast by Country 2021-2031 (US$ million)
Figure 92 North America Anti-Obesity Drugs Market Share Forecast by Country 2021, 2026, 2031 (%)
Figure 93 North America Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%)
Figure 94 North America Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 95 North America Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 96 North America Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 97 North America Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 98 North America Anti-Obesity Drugs Market Forecast by Type, 2021-2031 (US$ million, AGR%)
Figure 99 North America Anti-Obesity Drugs Market Forecast by Type, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 100 North America Anti-Obesity Drugs Market Forecast by Type, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 101 North America Anti-Obesity Drugs Market Forecast by Type, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 102 North America Anti-Obesity Drugs Market Forecast by Type, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 103 North America Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%)
Figure 104 North America Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 105 North America Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 106 North America Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 107 North America Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 108 North America Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%)
Figure 109 North America Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 110 North America Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 111 North America Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 112 North America Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 113 U.S. Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 114 U.S. Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 115 U.S. Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 116 U.S. Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 117 U.S. Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 118 Canada Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 119 Canada Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 120 Canada Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 121 Canada Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 122 Canada Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 123 Europe Anti-Obesity Drugs Market Forecast by Country 2021-2031 (US$ million)
Figure 124 Europe Anti-Obesity Drugs Market Share Forecast by Country 2021, 2026, 2031 (%)
Figure 125 Europe Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%)
Figure 126 Europe Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 127 Europe Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 128 Europe Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 129 Europe Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 130 Europe Anti-Obesity Drugs Market Forecast by Type, 2021-2031 (US$ million, AGR%)
Figure 131 Europe Anti-Obesity Drugs Market Forecast by Type, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 132 Europe Anti-Obesity Drugs Market Forecast by Type, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 133 Europe Anti-Obesity Drugs Market Forecast by Type, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 134 Europe Anti-Obesity Drugs Market Forecast by Type, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 135 Europe Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%)
Figure 136 Europe Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 137 Europe Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 138 Europe Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 139 Europe Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 140 Europe Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%)
Figure 141 Europe Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 142 Europe Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 143 Europe Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 144 Europe Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 145 Germany Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 146 Germany Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 147 Germany Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 148 Germany Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 149 Germany Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 150 UK Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 151 UK Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 152 UK Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 153 UK Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 154 UK Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 155 France Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 156 France Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 157 France Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 158 France Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 159 France Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 160 Italy Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 161 Italy Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 162 Italy Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 163 Italy Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 164 Italy Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 165 Spain Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 166 Spain Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 167 Spain Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 168 Spain Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 169 Spain Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 170 Russia Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 171 Russia Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 172 Russia Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 173 Russia Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 174 Russia Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 175 Rest of Europe Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 176 Rest of Europe Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 177 Rest of Europe Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 178 Rest of Europe Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 179 Rest of Europe Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 180 Asia Pacific Anti-Obesity Drugs Market Forecast by Country 2021-2031 (US$ million)
Figure 181 Asia Pacific Anti-Obesity Drugs Market Share Forecast by Country 2021, 2026, 2031 (%)
Figure 182 Asia Pacific Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%)
Figure 183 Asia Pacific Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 184 Asia Pacific Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 185 Asia Pacific Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 186 Asia Pacific Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 187 Asia Pacific Anti-Obesity Drugs Market Forecast by Type, 2021-2031 (US$ million, AGR%)
Figure 188 Asia Pacific Anti-Obesity Drugs Market Forecast by Type, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 189 Asia Pacific Anti-Obesity Drugs Market Forecast by Type, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 190 Asia Pacific Anti-Obesity Drugs Market Forecast by Type, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 191 Asia Pacific Anti-Obesity Drugs Market Forecast by Type, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 192 Asia Pacific Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%)
Figure 193 Asia Pacific Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 194 Asia Pacific Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 195 Asia Pacific Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 196 Asia Pacific Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 197 Asia Pacific Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%)
Figure 198 Asia Pacific Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 199 Asia Pacific Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 200 Asia Pacific Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 201 Asia Pacific Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 202 Japan Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 203 Japan Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 204 Japan Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 205 Japan Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 206 Japan Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 207 China Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 208 China Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 209 China Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 210 China Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 211 China Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 212 India Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 213 India Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 214 India Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 215 India Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 216 India Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 217 Australia Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 218 Australia Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 219 Australia Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 220 Australia Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 221 Australia Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 222 South Korea Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 223 South Korea Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 224 South Korea Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 225 South Korea Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 226 South Korea Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 227 South-East Asia Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 228 South-East Asia Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 229 South-East Asia Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 230 South-East Asia Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 231 South-East Asia Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 232 Rest of Asia Pacific Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 233 Rest of Asia Pacific Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 234 Rest of Asia Pacific Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 235 Rest of Asia Pacific Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 236 Rest of Asia Pacific Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 237 Latin America Anti-Obesity Drugs Market Forecast by Country 2021-2031 (US$ million)
Figure 238 Latin America Anti-Obesity Drugs Market Share Forecast by Country 2021, 2026, 2031 (%)
Figure 239 Latin America Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%)
Figure 240 Latin America Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 241 Latin America Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 242 Latin America Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 243 Latin America Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 244 Latin America Anti-Obesity Drugs Market Forecast by Type, 2021-2031 (US$ million, AGR%)
Figure 245 Latin America Anti-Obesity Drugs Market Forecast by Type, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 246 Latin America Anti-Obesity Drugs Market Forecast by Type, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 247 Latin America Anti-Obesity Drugs Market Forecast by Type, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 248 Latin America Anti-Obesity Drugs Market Forecast by Type, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 249 Latin America Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%)
Figure 250 Latin America Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 251 Latin America Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 252 Latin America Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 253 Latin America Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 254 Latin America Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%)
Figure 255 Latin America Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 256 Latin America Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 257 Latin America Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 258 Latin America Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 259 Brazil Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 260 Brazil Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 261 Brazil Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 262 Brazil Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 263 Brazil Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 264 Mexico Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 265 Mexico Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 266 Mexico Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 267 Mexico Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 268 Mexico Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 269 Rest of Latin America Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 270 Rest of Latin America Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 271 Rest of Latin America Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 272 Rest of Latin America Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 273 Rest of Latin America Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 274 Middle East and Africa Anti-Obesity Drugs Market Forecast by Country 2021-2031 (US$ million)
Figure 275 Middle East and Africa Anti-Obesity Drugs Market Share Forecast by Country 2021, 2026, 2031 (%)
Figure 276 MEA Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%)
Figure 277 MEA Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 278 MEA Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 279 MEA Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 280 MEA Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 281 MEA Anti-Obesity Drugs Market Forecast by Type, 2021-2031 (US$ million, AGR%)
Figure 282 MEA Anti-Obesity Drugs Market Forecast by Type, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 283 MEA Anti-Obesity Drugs Market Forecast by Type, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 284 MEA Anti-Obesity Drugs Market Forecast by Type, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 285 MEA Anti-Obesity Drugs Market Forecast by Type, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 286 MEA Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%)
Figure 287 MEA Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 288 MEA Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 289 MEA Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 290 MEA Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 291 MEA Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%)
Figure 292 MEA Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 293 MEA Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 294 MEA Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 295 MEA Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 296 GCC Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 297 GCC Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 298 GCC Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 299 GCC Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 300 GCC Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 301 South Africa Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 302 South Africa Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 303 South Africa Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 304 South Africa Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 305 South Africa Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 306 Rest of Middle East and Africa Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 307 Rest of Middle East and Africa Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 308 Rest of Middle East and Africa Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 309 Rest of Middle East and Africa Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 310 Rest of Middle East and Africa Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 311 Bristol-Myers Squibb: Net Revenue, 2015-2020 (US$ million, AGR%)
Figure 312 Bristol-Myers Squibb: R&D Expenses, 2015-2020 (US$ million, AGR%)
Figure 313 Bristol-Myers Squibb: Gross Profit, 2015-2020 (US$ million, AGR%)
Figure 314 Eisai Co. Ltd: Net Revenue, 2015-2020 (US$ million, AGR%)
Figure 315 Eisai Co. Ltd: R&D Expenses, 2015-2020 (US$ million, AGR%)
Figure 316 Eisai Co. Ltd: Gross Profit, 2015-2020 (US$ million, AGR%)
Figure 317 GlaxoSmithKline PLC: Net Revenue, 2015-2020 (US$ million, AGR%)
Figure 318 GlaxoSmithKline PLC: R&D Expenses, 2015-2020 (US$ million, AGR%)
Figure 319 GlaxoSmithKline PLC: Gross Profit, 2015-2020 (US$ million, AGR%)
Figure 320 Merck & Co. Inc.: Net Revenue, 2015-2020 (US$ million, AGR%)
Figure 321 Merck & Co. Inc.: R&D Expenses, 2015-2020 (US$ million, AGR%)
Figure 322 Merck & Co. Inc.: Gross Profit, 2015-2020 (US$ million, AGR%)
Figure 323 Novo Nordisk A/S: Net Revenue, 2015-2020 (US$ million, AGR%)
Figure 324 Novo Nordisk A/S: R&D Expenses, 2015-2020 (US$ million, AGR%)
Figure 325 Novo Nordisk A/S: Gross Profit, 2015-2020 (US$ million, AGR%)
Figure 326 Pfizer Inc.: Net Revenue, 2015-2020 (US$ million, AGR%)
Figure 327 Pfizer Inc.: R&D Expenses, 2015-2020 (US$ million, AGR%)
Figure 328 Pfizer Inc.: Gross Profit, 2015-2020 (US$ million, AGR%)
Figure 329 Rhythm Pharmaceuticals: R&D Expenses, 2015-2020 (US$ million, AGR%)
Figure 330 Vivus Inc.: Net Revenue, 2015-2020 (US$ million, AGR%)
Figure 331 Vivus Inc.: R&D Expenses, 2015-2020 (US$ million, AGR%)
Figure 332 Vivus Inc.: Gross Profit, 2015-2020 (US$ million, AGR%)
Figure 333 CohBar: R&D Expenses, 2015-2020 (US$ million, AGR%)
Figure 334 Hanmi Pharmaceutical, Co., Ltd.: Net Revenue, 2015-2020 (US$ million, AGR%)
Companies Profiled in the Report
Bristol-Myers Squibb
Carmot Therapeutics
CohBar
Currax Pharmaceuticals LLC
Eisai Co. Ltd
ERX Pharmaceuticals
Gelesis
GlaxoSmithKline PLC
Hanmi Pharmaceutical, Co., Ltd.
Merck & Co. Inc.
Novo Nordisk A/S
Pfizer Inc.
Rhythm Pharmaceuticals
Saniona
Scohia Pharma, Inc.
Vivus Inc.
YSOPIA Bioscience
List of Other Companies
Adipo Therapeutics
Allurion Technologies
Calibrate
CiiTECH
EnteroMedics
EraCal Therapeutics
Form Health
Kintai Therapeutics
MelliCell
Neurovalens
Noom
Oviva
Phenomix Sciences
Phyteau
ReShape Lifesciences
ValenTx
Viome
Zen Eating
List of Organizations Mentioned in the Report
Advancing Research in Obesity (AIAARO)
American Board of Obesity Medicine
American Diabetes Association
American Obesity Association
American Obesity Treatment Association (AOTA)
Associacao Nacional de Assistencia ao Diabetico (ANAD, Brazil)
Association for the Study of Obesity
Association of the European Self-Medication Industry
Bariatric Surgery Society of India
Canadian Institute for Health Information
Center for Drug Evaluation and Research
European Association for the Study of Obesity (EASO)
European Medicines Agency
European Medicines Agency (EMA)
Food and Drug Administration (US FDA)
French Ministry of Health
International Diabetes Federation (IDF)
International Federation for the Surgery of Obesity and Metabolic Disorders
MD Anderson Cancer Center
Medicines and Healthcare products Regulatory Agency
Ministry of Health (MoH, Germany)
Ministry of Health, Labour and Welfare
Ministry of Health, Labour and Welfare (MHLW, Japan)
National Health Service (NHS, UK)
National Institute of Health and Clinical Excellence (NICE, UK)
Obesity Medicine Association
Pharmaceutical and Medical Devices Agency
Stanford University School of Medicine
State Food and Drug Administration
The Association for the Study of Obesity on the Island of Ireland (ASOI)
The International Association for the Study of Obesity
The Obesity Society
World Health Organization (WHO)
World Obesity Federation
Bristol-Myers Squibb
Carmot Therapeutics
CohBar
Currax Pharmaceuticals LLC
Eisai Co. Ltd
ERX Pharmaceuticals
Gelesis
GlaxoSmithKline PLC
Hanmi Pharmaceutical, Co., Ltd.
Merck & Co. Inc.
Novo Nordisk A/S
Pfizer Inc.
Rhythm Pharmaceuticals
Saniona
Scohia Pharma, Inc.
Vivus Inc.
YSOPIA Bioscience
List of Other Companies
Adipo Therapeutics
Allurion Technologies
Calibrate
CiiTECH
EnteroMedics
EraCal Therapeutics
Form Health
Kintai Therapeutics
MelliCell
Neurovalens
Noom
Oviva
Phenomix Sciences
Phyteau
ReShape Lifesciences
ValenTx
Viome
Zen Eating
List of Organizations Mentioned in the Report
Advancing Research in Obesity (AIAARO)
American Board of Obesity Medicine
American Diabetes Association
American Obesity Association
American Obesity Treatment Association (AOTA)
Associacao Nacional de Assistencia ao Diabetico (ANAD, Brazil)
Association for the Study of Obesity
Association of the European Self-Medication Industry
Bariatric Surgery Society of India
Canadian Institute for Health Information
Center for Drug Evaluation and Research
European Association for the Study of Obesity (EASO)
European Medicines Agency
European Medicines Agency (EMA)
Food and Drug Administration (US FDA)
French Ministry of Health
International Diabetes Federation (IDF)
International Federation for the Surgery of Obesity and Metabolic Disorders
MD Anderson Cancer Center
Medicines and Healthcare products Regulatory Agency
Ministry of Health (MoH, Germany)
Ministry of Health, Labour and Welfare
Ministry of Health, Labour and Welfare (MHLW, Japan)
National Health Service (NHS, UK)
National Institute of Health and Clinical Excellence (NICE, UK)
Obesity Medicine Association
Pharmaceutical and Medical Devices Agency
Stanford University School of Medicine
State Food and Drug Administration
The Association for the Study of Obesity on the Island of Ireland (ASOI)
The International Association for the Study of Obesity
The Obesity Society
World Health Organization (WHO)
World Obesity Federation
Download sample pages
Complete the form below to download your free sample pages for Anti-obesity Drugs Market Report 2021-2031Related reports
-
Metabolic Disorder Therapeutics Report 2020-2030
Metabolic Disorder Therapeutics– our new study reveals trends, R&D progress, and predicted revenues
Where is the Metabolic Disorder Therapeutics market...Full DetailsPublished: 01 January 1970 -
Non-alcoholic Fatty Liver Disease (NAFLD) & NASH Market Report 2021-2031
The report study aims to explore the market drivers, restraints and also market opportunities facing non-alcoholic fatty liver disease &...Full DetailsPublished: 17 February 2021 -
Global Sugar Substitutes Market Report 2019-2029
The consumption of sugar results in tooth decay as the bacteria present in dental plaque metabolise sugar and release acid...
Full DetailsPublished: 01 January 1970
Download sample pages
Complete the form below to download your free sample pages for Anti-obesity Drugs Market Report 2021-2031Do you have any custom requirements we can help you with?
Any specific country, geo region, market segment or specific company information?
Email us today, we can discuss your needs and see how we can help: jamie.roberts@visiongain.com
Would you like a free report overview of the report of your choice?
If so, please drop an email to Jamie Roberts stating your chosen report title to jamie.roberts@visiongain.com
Visiongain’s reports are based on comprehensive primary and secondary research. Those studies provide global market forecasts (sales by drug and class, with sub-markets and leading nations covered) and analyses of market drivers and restraints (including SWOT analysis) and current pipeline developments. To find out more about our reports methodology, please email jamie.roberts@visiongain.com
“Thank you for this Gene Therapy R&D Market report and for how easy the process was. Your colleague was very helpful and the report is just right for my purpose. This is the 2nd good report from Visiongain and a good price.”
Dr Luz Chapa Azuella, Mexico
American Association of Colleges of Pharmacy
American College of Clinical Pharmacy
American Pharmacists Association
American Society for Pharmacy Law
American Society of Consultant Pharmacists
American Society of Health-System Pharmacists
Association of Special Pharmaceutical Manufacturers
Australian College of Pharmacy
Biotechnology Industry Organization
Canadian Pharmacists Association
Canadian Society of Hospital Pharmacists
Chinese Pharmaceutical Association
College of Psychiatric and Neurologic Pharmacists
Danish Association of Pharmaconomists
European Association of Employed Community Pharmacists in Europe
European Medicines Agency
Federal Drugs Agency
General Medical Council
Head of Medicines Agency
International Federation of Pharmaceutical Manufacturers & Associations
International Pharmaceutical Federation
International Pharmaceutical Students’ Federation
Medicines and Healthcare Products Regulatory Agency
National Pharmacy Association
Norwegian Pharmacy Association
Ontario Pharmacists Association
Pakistan Pharmacists Association
Pharmaceutical Association of Mauritius
Pharmaceutical Group of the European Union
Pharmaceutical Society of Australia
Pharmaceutical Society of Ireland
Pharmaceutical Society Of New Zealand
Pharmaceutical Society of Northern Ireland
Professional Compounding Centers of America
Royal Pharmaceutical Society
The American Association of Pharmaceutical Scientists
The BioIndustry Association
The Controlled Release Society
The European Federation of Pharmaceutical Industries and Associations
The European Personalised Medicine Association
The Institute of Clinical Research
The International Society for Pharmaceutical Engineering
The Pharmaceutical Association of Israel
The Pharmaceutical Research and Manufacturers of America
The Pharmacy Guild of Australia
The Society of Hospital Pharmacists of Australia
Visiongain Pharma
Visiongain Pharma
Visiongain PharmaLatest Pharma news
Visiongain Publishes Drug Delivery Technologies Market Report 2024-2034
The global Drug Delivery Technologies market is estimated at US$1,729.6 billion in 2024 and is projected to grow at a CAGR of 5.5% during the forecast period 2024-2034.
23 April 2024
Visiongain Publishes Cell Therapy Technologies Market Report 2024-2034
The cell therapy technologies market is estimated at US$7,041.3 million in 2024 and is projected to grow at a CAGR of 10.7% during the forecast period 2024-2034.
18 April 2024
Visiongain Publishes Automation in Biopharma Industry Market Report 2024-2034
The global Automation in Biopharma Industry market is estimated at US$1,954.3 million in 2024 and is projected to grow at a CAGR of 7% during the forecast period 2024-2034.
17 April 2024
Visiongain Publishes Anti-obesity Drugs Market Report 2024-2034
The global Anti-obesity Drugs market is estimated at US$11,540.2 million in 2024 and is expected to register a CAGR of 21.2% from 2024 to 2034.
12 April 2024
